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Posttranslational Modification of Histone 1.4 by SET7/9 and ARTD1 Zusammenfassung 
  1 
1. Zusammenfassung Proteine	   sind	   sehr	   wichtig	   für	   die	   Steuerung	   von	   biochemischen	   Prozessen	   und	  verleihen	  den	  Zellen	   ihre	  Struktur	  und	  Funktion.	  Proteine	  werden	  nach	   ihrer	  Bildung	  (d.h.	  posttranslational)	  meist	  zusätzlich	  chemisch	  modifiziert,	  um	  deren	  Funktion	  und	  enzymatische	  Aktivität	  zu	  regulieren.	  	  In	  der	  vorliegenden	  Arbeit	  wurde	  gezeigt,	  dass	  die	  Monomethyltransferase	  SET7/9	  spezifisch	   die	   C-­‐terminale	   Domäne	   der	   Histonvariante	   H1.4	   an	   bestimmten	   Lysinen	  modifiziert	  (K121,	  K129,	  K159,	  K171,	  K177	  und	  K192).	  Die	  Lysine	  befinden	  sich	  jeweils	  am	  Ende	  der	  Konsensus-­‐Sequenz	  KAK.	  Ausserdem	  verhinderte	  die	  Zugabe	  von	  DNS	  zur	  Methylierungsreaktion	   die	   Modifikation	   von	   H1.4	   durch	   SET7/9.	   Die	  Expressionsanalyse	   von	   GFP	   fusioniert	  mit	   dem	   ganzen	  H1.4	   oder	   nur	  mit	   dessen	   C-­‐	  oder	   N-­‐terminalen	   Domäne	   in	   U2OS	   Zellen	   zeigte,	   dass	   alle	   drei	   Fusionsproteine	  entweder	  im	  Hetero-­‐	  oder	  Euchromatin	  des	  Nukleus	  lokalisiert	  sind.	  Zudem	   wurde	   gezeigt,	   dass	   H1.4	   an	   etlichen	   Positionen	   durch	   die	   ADP-­‐Ribosyltransferase	   ARTD1	   modifiziert	   wird.	   Die	   durch	   ARTD1	   vermittelte	   ADP-­‐Ribosylierung	  wurde	  vor	  allem	  in	  der	  C-­‐terminalen	  Domäne	  gefunden	  und	  unterdrückte	  die	  durch	  SET7/9	  vermittelte	  Methylierung	  von	  H1.4.	  Dieser	   gegenseitige	   Ausschluss	   dieser	   zwei	   posttranslationalen	   Modifikationen	  bestärkt	   die	   Hypothese,	   dass	   posttranslationale	   Modifikationen	   von	   strukturnahen	  Aminosäuren	   sich	   gegenseitig	   beeinflussen	   und	   so	   die	   Funktionalität	   des	   Proteins	  regulieren	  können.	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2 Summary Proteins	   are	   important	   for	   the	   regulation	   of	   biochemical	   processes	   and	   are	  crucial	   for	   the	   structure	   and	   function	   of	   cells.	   Proteins	   are	   post-­‐translationally	   often	  chemically	  modified,	  which	  regulates	  their	  function	  and	  enzymatic	  activities.	  The	   work	   presented	   in	   this	   thesis	   shows	   that	   the	   mono-­‐methyltransferase	  SET7/9	  modifies	  the	   linker	  histone	  H1.4	  only	  at	  the	  C-­‐terminal	  domain.	  Several	   lysine	  residues	  (K121,	  K129,	  K159,	  K171,	  K177	  and	  K192)	  were	  identified	  to	  be	  methylated.	  SET7/9	   only	  modified	   lysine	   residues	   at	   the	   terminal	   position	   of	   a	   given	   KAK	  motif.	  Also,	  the	  addition	  of	  DNA	  to	  the	  methylation	  reaction	  inhibited	  the	  modification	  of	  H1.4	  by	  SET7/9.	  Expression	  analysis	   of	  GFP-­‐tagged	   full	   length	  H1.4	  or	   its	  C-­‐terminal	   or	  N-­‐terminal	   fragments	   in	   U2OS	   cells	   suggested	   that	   all	   fusion	   proteins	   localize	   to	   either	  hetero-­‐	  or	  euchromatin	  in	  the	  nucleus.	  Furthermore,	   the	   ADP-­‐ribosyltransferase	   ARTD1	   modified	   several	   amino	   acid	  residues	  in	  the	  C-­‐terminal	  domain	  of	  H1.4,	  a	  process	  that	  inhibited	  SET7/9-­‐dependent	  methylation.	   This	   mutual	   exclusion	   of	   the	   two	   modifications	   suggests	   that	   post-­‐translational	  modification	  of	  structurally	  close	  amino	  acids	  can	  influence	  each	  other	  and	  thereby	  regulate	  the	  functionality	  of	  proteins.	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3 Abbreviations 
3-AB  3-aminobenzamide 
aa  Amino acid(s) 
ADP  Adenosine diphosphate 
AMD  Automodification domain 
AMPK AMP-activated protein kinase 
ARH  ADP-ribosyl hydrolase 
ARTD  ADP-ribosyltransferase diphtheria toxin-like 
ATP  Adenosine triphosphate 
bp  base pairs 
BB  Binding buffer 
BRCT  BRCA1 C-terminus 
BSA  Bovine serum albumin 
CDK  Cyclin-dependent kinase 
Cl  Cluster 
CTD  Carboxy-terminal domain 
DBD  DNA binding domain 
DNA  Deoxyribonucleic acid 
DNS  Desoxyribonukleinsäure 
dNTP’s deoxy Nucleotide-Tri-Phosphates 
DSB  DNA double-strand break 
EB  Elution buffer 
Ezh2  Enhancer of zeste homolog 2 
FL  Full-length 
Fr  Fragment 
GFP  Green fluorescence protein 
GST  Glutathione S-transferase 
H1  Histone 1  
H2A  Histone 2A 
H2B  Histone 2B 
H2O2  Hydrogen peroxide 
H3   Histone 3 
H4  Histone 4 
HIF  Hypoxia inducible factor 
His  Polyhistidine 
HMG  High mobility group 
HP1  Heterochromatin protein 1 
HR  Homologous recombination 
K  Lysine 
KMT  Lysine methyl transferas 
LPS  Lipopolysaccharide 
LSD  Lysine specific demethylase 
ml  Milliliter 
mM  Millimolar 
NAD+  Nicotinamide adenine dinucleotide 
nCi  Nanocurie 
NEB  New England Biolabs 
NF-κB  Nuclear factor κB 
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ng  Nanogramm 
NLS  Nuclear localization signal 
NTD  Amino-terminal domain 
PAR  Poly(ADP-ribose) 
PARG  Poly(ADP-ribose) glycohydrolase 
PARP  Poly(ADP-ribose) polymerase 
PARylation Poly(ADP-ribosyl)ation 
PBS  Phosphate buffered saline 
PCR  Polymerase Chain Reaction 
pH  Power of hydrogen 
PRMT  Arginine methyl transferase 
R  Arginine 
SAM  S-adenosylmethionine 
SDS-PAGE Sodium-dodecyl-sulfate polyacrylamide gel electrophoresis 
SET  Su(var)3-9, Enhancer-of-zeste, Trithorax 
TBS  Tris buffered saline 
TBS-T  Tris buffered saline Tween 20 
WB  Washing buffer 
WGR  Tryptophan-glycine-arginine motif 
wt  Wild type 
ZBD  Zinc binding domain 
ZF  Zinc finger 
µl  Microliter 
µM  Micromolar 
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4 Introduction 
4.1 Chromatin 
The human genome consists of 3.2x109 nucleotide bases that form a linear chain of 
around 2 m in length (roughly 100’000 times the size of a cell) 1. To fit into the nucleus of 
the cell, the DNA thus has to be tightly compacted. Since each eukaryotic cell contains 
exactly one copy of the entire genome, the condensation of the DNA is absolutely required. 
The compaction of the DNA is controlled through structural arrangements of the DNA with 
histones and non-histone proteins, which together form the chromatin 2 (Fig. 1).  
 
 
Figure 1: DNA compaction within the interphase nucleus occurs through different histone-dependent 
interactions. The ‘beads on a string’ structure (10 nm fiber) is formed by wrapping DNA around nucleosomes. 
Histone tail-mediated nucleosome-nucleosome interactions induce the formation of the 30 nm fiber and an even 
higher compaction is accomplished through tail-mediated association of individual fibers 3. 
 
This chromatin structure is a drawback for genomic activities such as replication, 
transcription, repair or recombination, because it restricts the accessibility of the DNA. 
Hence, there has to be a mechanism that makes the DNA more accessible in response to 
different stimuli. Exchanging or chemically modifying histones can mediate this needed 
change of the chromatin structure 2. There are two major states of chromatin: euchromatin 
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and heterochromatin. Euchromatin constitutes the less condensed chromatin that is more 
accessible for regulatory proteins. Heterochromatin, on the other hand, represents the 
compact state of chromatin, which is tightly folded and inaccessible. These distinct states are 
each associated with a special set of histone modifications 4. Beyond that, we observe 
additional chromatin states with intermediate condensation levels. 
 
4.1.1 Structure and Organization of Chromatin  
Nucleosomes are the most basic unit of the chromatin and consist of DNA that is 
wrapped around histones. One nucleosome has a diameter of 10 nm and achieves a 7-fold 
compaction of the DNA 2,5. The nucleosome consists of the four core histones H2A, H2B, H3, 
H4 and the linker histone H1, which are the most abundant proteins in chromatin 2. Histones 
are basic proteins and contain many positively charged amino acids, which allows them to 
interact with the negatively charged DNA. The variable linker region between two 
nucleosomes can be bound by histone H1, which seals two rounds of DNA at its entry/exit 
site on the surface of the nucleosome core 6. In the presence of the linker histone H1, six 
nucleosomes from the ‘beads on a string’ conformation condense to form the 30 nm fiber, 
which represents a higher level of DNA condensation. This leads to an overall compaction of 
the linear DNA by factor of 30 to 40 7. With the help of additional factors such as non-
histone and nuclear scaffold proteins, large chromatin loop domains can be established. 
Those are further compacted to generate interphase and mitotic chromosomes 2. At the end, 
chromonema fibers represent the highest organized state of chromatin 8. These chromatin 
alterations achieve a very moldable structure, which allow cellular DNA-associated processes 
to be performed, while maintaining the capability of cell division and equal distribution of 
the DNA to the daughter cells. 
 
4.1.2 Non-histone Proteins 
One-third of the mass of mitotic chromosomes is comprised of chromatin-associated 
non-histone proteins, of which some even remain associated with the chromatin after removal 
of the histones 9. Non-histone proteins comprise many different types, such as high mobility 
group (HMG) proteins, scaffold proteins, DNA topoisomerases and DNA polymerases. All of 
these proteins regulate different functions that assure the maintenance of the chromosomal 
structure and integrity. Furthermore, non-histone proteins play a role in mitotic events such 
Posttranslational Modification of Histone 1.4 by SET7/9 and ARTD1 Introduction 
  9 
as chromosomal condensation, sister chromatid separation and interaction of the 
chromosomes with the cytoskeleton during spindle formation 9. 
 
4.2 Histone Proteins 
The five different histones (H2A, H2B, H3, H4 and H1) in mammalian cells are 
mostly expressed during S-phase and incorporated into chromatin in a DNA replication-
dependent manner. It is proposed that core and linker histones may have evolved from totally 
different genes of eubacteria and archaea. Their variation is thus reflecting the increasing 
complexity during eukaryotic evolution 10. 
Each histone is structured into one core domain, which is flanked by two tail domains. 
The core domain allows protein-protein interactions and induces compaction of the DNA 11. 
Not only the N- but also the C-terminal tails can be altered by posttranslational modifications 
and thereby regulate the interaction with DNA 6. Histone modifications can neutralize the 
positive charge of the histone tails, which results in a reduced interaction with the negatively 
charged phosphate backbone of the DNA. Therefore, modified chromatin (e.g., acetylated 
lysine residues) is often less compacted and better accessible for proteins involved in 
processes such as DNA-repair, recombination, replication or transcription 4. 
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4.2.1 Core Histones 
The nucleosome core particle consists of 2 copies of each core histone H2A, H2B, H3, 
and H4, which form dimers and assemble into an octamer that is enwrapped by 145-147 base 
pairs of DNA 12 (Fig 2).  
 
A      B 
 
Figure 2: A nucleosome with core histone proteins H2A (orange), H2B (green), H3 (blue) and H4 (red) and a 
147-bp DNA strand. A: 1.9-Å nucleosome core particle structure with the DNA strand shown in silver and red. 
The black arrows mark the N-terminal rails of the histone proteins, which are targets of many post-translational 
modifications. B: A cartoon diagram to clearly illustrate the positions of the core histone proteins 13.  
 
The H3-H4 tetramer strongly interacts with the nucleosomal DNA and the N-terminal 
tails of the histones H3 and H4 leave the nucleosomal core close to where DNA enters or 
exits the nucleosome 4. In contrast, the histones H2A and H2B associate more weakly with 
the DNA of the nucleosome 14 and are frequently displaced from nucleosomes 11. Therefore, 
post-translational modifications on these histones play a less important role than on histones 
H3 and H4 15.  
 
4.2.2 Core Histone Variants 
Throughout evolution, the general structure of chromatin has been conserved. 
However, histone variants, which can be incorporated into nucleosomes to regulate the 
chromatin barrier, have evolved in vertebrates 16. Histone variants differ only in a few amino 
acids from their original counterparts and are mainly expressed in different cell cycle phases. 
Incorporation into the chromatin happens mainly in a DNA replication-independent 
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manner 17. In core histones, histone H2B and H4 are mostly invariant, whereas H2A and H3 
are exchanged more frequently. 
Histone H2A variants can be grouped into the replicative histone variants H2A.1 and 
H2A.2, synthesized in S-phase in a replication-coupled manner, and the replacement variants 
H2Av (H2A.X/H2A.Z), Htz1 (H2A.Z), macroH2A and H2ABbd, which are expressed either 
constitutively throughout the cell cycle or outside of S-phase 18. H2A.X, the best-studied 
variant, is phosphorylated at its C-terminal SQ (E/D) motif upon treatment with DNA-
double-strand break inducing agents 19. This phosphorylation of H2A.X is crucial for the 
recruitment of DNA-repair proteins 20. MacroH2A is much larger than the other H2As, 
because it contains a non-histone macro-domain at the C-terminus 21. Nucleosomes 
containing macroH2A participate only weakly in ADP-dependent remodeling, chaperone-
mediated histone exchange, transcription factor binding or transcriptional activation by 
Pol II 22. Another histone variant, H2A.Z, is more prominent at promoters, which are 
competent for transcriptional activation 23. Rapid eviction of H2A.Z is needed for full 
transcriptional activation and elongation, since H2A.Z containing nucleosomes are resistant 
to chromatin remodeling and modifications 24. H2ABbd activates transcription and is found 
on active X-chromosomes and autosomes 17. 
The group of histone H3 variants consists of H3.1 and H3.2, which are the replicative 
variants, and the replacement variants H3.3 and CENP-A. The major H3 variant is CENP-A 
that is found in centromere-regions of chromosomes and is essential for centrosome function. 
Other variants, for example H3.3, are generally expressed in transcriptionally active 
chromatin and involved in the regulation of transcription 25. 
 
4.2.3 Linker Histone H1 
The linker histone H1 is less evolutionarily conserved than the core histones. Multiple 
non-allelic variants are expressed in eukaryotes and can even be tissue specific. Eleven 
different subtypes have been identified in mammals, but very little is known about their 
specific functions. Much data suggest that H1 has a critical role in controlling the higher 
order chromosomal structure 26. It was shown that H1 is required for normal morphology of 
replicated mitotic chromosomes 27. Histone H1 is rather involved in the regulation of specific 
genes and in specific processes than producing global effects on transcription. Depletion of 
H1.2 and H1.4 resulted in an arrest of cell proliferation, while the loss of H1.0, H1.3 or H1.5 
had no effect on cell growth 6,28.  
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4.2.4 Linker Histone H1 Variants 
The vast variety of H1 variants (7 are somatic (H1.1-H1.5, H1.0 and H1x), 4 are 
expressed in germ cells (H1t, H1T2, HILS1, H1oo)), and the fact that some are only 
expressed in specific tissues or at certain stages of development, led to the suggestion that 
these defined patterns may have specific functions 29.  
In general, H1.2 to H1.5 are found in nearly all cells, while H1.2 and H1.4 are the 
main variants in most somatic cells 30. H1oo is only expressed in oocytes, starting from the 
primordial follicle stage to early embryogenesis. H1t, H1T2 and the variant HILS1 are only 
found in sperm cells 6,31, while H1x has been found in different cell types 32. Some cell types 
depend on linker histone H1.0 for their terminal differentiation 33. However, mice lacking the 
H1.0 protein did not exhibit impaired growth or reproduction and the stoichiometry of H1 to 
nucleosome did not change. This result suggests that the other main histone H1 types 
compensated the loss of H1.0. The same outcome was observed when the pachytene specific 
subtype H1t was deleted 34 or when the main type H1.1 was depleted 35. Even after deletion 
of two of the three main histone H1 types, there was no phenotypic change 36. The deletion of 
all three H1 subtype genes led to decondensation of chromatin and changes in core histone 
modification and the mice died around mid-gestation 37,38. 
A functional role of individual histone H1 subvariants, in addition to their structural 
impact on chromatin, is well supported, but more studies are needed to determine these 
differential functions of individual histone variants. The structural function seems to be 
subtype independent, since the single deletion of distinct linker histones genes can be 
compensated 6.  
 
4.2.5 Structure of the Linker Histone H1 
The three-domain structure of the core histones is also found in histone H1. With a 
length of 20-35 amino acids, the N-terminal tail is relatively short and enriched in basic 
amino acids. The first half of the N-terminus is highly hydrophobic 26. The central domain  of 
H1 consists of 75 amino acids, is highly conserved among all the subtypes, and has a globular 
conformation 39. Forming the extended part of the histone with approximately 100 amino 
acids, the C-terminal domain is highly enriched in lysine, alanine and proline. It varies 
significantly between the different subtypes and species 26 (Fig. 3).  
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Figure 3: H1 variants vary the most in the C-terminal domain. Alignment of the H1 variants H1.2, H1.4 and H1t. 
Functionally similiar amino acids are marked in the same color. 
 
This C-terminal domain acquires a specific secondary structure when bound to 
DNA 40, stabilizes the folding of the nucleosome array into chromatin fibers, and is needed 
for the high-affinity binding to chromatin 41.  
 
4.2.6 Linker Histone and binding to Chromatin 
H1 histones promote tighter packing of chromatin, condensation from the ‘beads on a 
string’ conformation to the 30 nm fiber, and limit the access for regulatory proteins to 
nucleosomal components 42. Through the globular domain, histone H1 binds the entering and 
exiting DNA at the surface of the nucleosome at least twice and thus stabilizes the DNA 
wrapping 39. Two contradictory models suggested different positioning characteristics of H1 
based on studies of formation of nucleosomes on DNA in vitro. One model proposes that the 
globular H1 domain bridges two DNA duplexes between the dyad and one of the 
chromosomal DNA ends 43. According to the alternative hypothesis, the globular H1 domain 
is placed 65 base pairs away from the nucleosome dyad inside of one of two chromosomal 
DNA turns 44. Newer studies indicated a two site-model, in which one α-helix of the winged 
helix element of the globular domain interacts with DNA at a distance of approximately one 
helical turn away from the nucleosomal dyad. About 15 nucleotide pairs away from the 
nucleosomal core DNA is the second proposed site 39.  
According to the structure, the N-terminal H1 domain has only minimal effects on 
chromatin binding and is not expected to bind to the DNA 45. The most divergent part of H1, 
the C-terminal domain, is at the same time the main determinant of the binding of H1 
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subtypes to chromatin 41. Specific subdomains of the C-terminal linker histone domain 
mediate this effect 6. An interaction between the linker histone and the C-terminal tail of the 
core histone H2A was found, but the precise binding sites are still unknown. However, 
identifying interaction partners of H2A by mass spectrometry only revealed peptides 
corresponding to H1.1 and H1.2, while no peptides corresponding to core histones were 
detected. Further experiments suggest that the H2A C-terminus is required for efficient H1 
binding to the nucleosome in vivo 46. 
H1 limits the mobility of nucleosomes and the accessibility of chromosomal DNA for 
chromatin remodeling complexes through its interaction with chromatin (Fig 4). 
 
 
Figure 4: Chromatin compaction induced by linker histone H1. A more closed conformation of the linker DNA 
and overall of chromatin is achieved when H1 binds to nucleosomes. 
 
Nevertheless, H1 was identified as a highly mobile chromatin element in comparison to the 
core histones. Interactions between H1 and the nucleosome are transient and last only for 3 to 
4 minutes before histone H1 dissociates and quickly interacts with another binding site 47,48. 
Thus, linker histone H1 travels more slowly than most other chromatin binding proteins and 
is influenced by competition with other proteins, for example of the high mobility group 42. 
The binding affinity of the different H1 subtypes correlates with the length of the C-terminal 
domain. The most mobile subtypes are H1.1 and H1.2, H1.0 and H1.3 exhibit moderate 
affinity, and H1.4 and H1.5 have the highest affinity 45. Additional modulation of the kinetics 
of H1 exchange can be achieved by H1 modification and by interaction of H1 with other 
structural protein components of chromatin. For example, it was shown that ongoing 
phosphorylation is needed for histone H1 mobility 48.  
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4.3 Posttranslational Modification (PTM) 
Posttranslational protein modifications are reversible modifications that are added 
after the translation of proteins. Specific chemical groups are enzymatically attached and 
thereby affect the structure, function and biological activity of the modified proteins. The 
core histones are modified at over 60 different amino acids on their N-terminal tails 4. The 
highest number of modifications has been recorded for H3, followed by H4, H2B and H2A. 
The C-terminal tails of these core histones and their non-tail regions are modified to a lesser 
extent. 
Various modifications such as acetylation, methylation, phosphorylation, 
ubiquitination, sumoylation, ADP-ribosylation, N-formylation, deamination and proline 
isomerization have been reported for all five histones 4. The multitude of posttranslational 
modifications creates immense possibilities for the regulation of functional responses within 
the cell, which is an important mechanism in epigenetics 49. The proposed “histone code” 
greatly regulates the access to the information of the genetic code. The covalent 
modifications of histone proteins can modify chromatin structure, thereby changing between 
transcriptional active or silent chromatin states 50. Here, only PTMs on histone H1 are 
discussed, due to the focus on the linker histone. 
 
4.3.1 Epigenetics 
Epigenetics is defined as heritable changes in gene expression or cellular phenotype 
that occur without changes in the underlying DNA sequence. The genetic information 
encoded in DNA is the basis for the phenotype of an organism, but the definite genesis of this 
phenotype is controlled by the accessibility of the DNA sequence (i.e., transcription of genes). 
This regulation can either be transient or stably imprinted by biochemical modifications. 
DNA methylation and histone modifications by acetylation, methylation, phosphorylation, 
ubiquitination, ADP-ribosylaion and others are reactions that lead to such a regulation 51. 
These modifications are targeted at specific sites in multiple ways.  
More and more evidence suggests that the epigenetic information from the 
combination of different histone modifications and various histone variants is fundamental 52. 
Thus, the research of histone proteins and their posttranslational modifications has received 
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progressively more attention as further results confirm the importance of chromosomal 
proteins. 
 
4.3.2 Posttranslational Modifications of the Linker Histone H1 
In the linker histone H1, the N-terminal tail (aa 1-36) can be modified, but to a lesser 
extent than the globular domain (aa 37-113) and the C-terminal tail (aa 114-219)49. The most 
abundant modifications found in H1 are phosphorylation, acetylation, methylation, 
ubiquitination and the recently discovered N-formylation 53. Phosphorylation of histone H1 is 
the best-studied modification and progressively increases during the cell cycle. The majority 
of the H1 phosphorylation sites lie within the cycline-dependent kinase (CDK) motif 
(S/T)PX(K/R), which is important for DNA binding of H1 54. The number of CDK motifs, 
the degree of phosphorylation, and the functional outcome during the cell cycle differ within 
the variants of H1 55. During late G2 and mitosis, phosphorylation becomes maximal and 
decreases again towards the end of mitosis in telophase 56. This led to the belief that 
phosphorylation of H1 decondensates DNA as a precondition for DNA replication 57. It has 
also been shown that H1 phosphorylation increases its dynamic exchange in chromatin 48. 
Therefore, H1 dephosphorylation and the consequential tighter binding between H1 and 
DNA are also considered important for the process of differentiation 39,41. Nevertheless, 
phosphorylation not only affects the interaction of histone H1 with the core nucleosome, but 
also with heterochromatin proteins 58.  
The most frequent covalent modifications in core histones are acetylation and 
methylation of lysine or arginine. Deacetylation of the strongly conserved lysine-26 in H1.4 
leads to the formation of heterochromatin 59 and methylation of the same lysine promotes 
repression of transcription 60. Activation of transcription is generally related with acetylation 
of core histones, while methylation is either seen at sites of activation or at repressed 
locations of the genome 17. The same results were observed for the linker histone H1, which 
demonstrates that histone H1 also contributes to the ‘histone code’ just as the core histones 
do. 
 
4.4 Lysine Methylation 
Methylation of histones regulates the formation and maintenance of heterochromatin, 
X-chromosome inactivity, transcription, DNA repair and genomic imprinting 61. Depending 
Posttranslational Modification of Histone 1.4 by SET7/9 and ARTD1 Introduction 
  17 
on the site and the degree, histone methylation can be an activating or repressing mark 62,63. 
For example, methylation of K4, K36 and K79 on histone 3 is associated with 
transcriptionally active chromatin, while methylation of K9 and K27 on H3 or K20 on H4 are 
rather found with compacted chromatin 62. 
Methylation does not change the charge of the acceptor, but impacts its basicity, 
hydrophobicity and the affinity of molecules such as transcription factors towards DNA 61. In 
all cases, methyl groups are transferred to the target site by using S-adenosylmethionine 
(SAM) as a co-substrate 64. Histone methylation occurs on lysine (mono-, di-, or 
trimethylated) (Fig 5) or arginine (mono- or dimethylated) residues and is catalyzed by 
histone methyltransferases (HMTs) 65.  
 
 
Figure 5: Methylation of lysine in histones can occur as mono-, di- or tri-methylation by histone 
methyltransferases (HMT). The methyl-groups are marked in red 66. 
 
Three different enzyme groups are able to methylate histones: SET domain lysine 
methyltransferases, non-SET domain lysine methyltransferases, and arginine 
methyltransferases 51. Histone methyltransferases are generally specific for the acceptor 
amino acids, as their name suggests, but several of them target also non-histone protein 
substrates. Thus, their proposed high specificity is debatable 51.  
Lysine methylation is a reversible modification. The recently discovered lysine 
specific demethylase 1 (LSD1) is part of a histone modification complex, which controls cell 
specific gene expression 67. The demethylase can remove the methyl group from 
nucleosomes, which proves that protein lysine methylation is a reversible posttranslational 
modification 67-69. Both, LSD1 and the closely related LSD2 70 remove the methyl group from 
lysines by forming of an imine intermediate, which undergoes hydrolysis to complete the 
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demethylation. This pathway only allows the demethylation of mono- and dimethylated 
lysines 71. On the other hand, Jumonji-C domain containing demethylases are also able to 
demethylate trimethylated lysine residues 72. 
 
4.5 Lysine Methyltransferase (KMT) SET7/9 
SET7/9 was discovered as a histone methyltransferase that catalyzes mono-
methylation of histone 3 lysine 4 (H3K4), but it shows only a weak activity on nucleosomes, 
which implies that the main targets of the enzyme are non-histone proteins 73-75 (Fig. 6). 
Protein dimethylation by SET7/9 has been described in some cases, but the enzyme mostly 
acts as a mono-methyltransferase 76,77. 
 
Figure 6: Crystal structure of human SET7/9. The C-SET, SET and N-SET domains of the human SET7/9 are 
shown as well as the pseudo knot, which is formed by two conserved SET motifs. Also, a bound H3 is indicated 
as well as the reaction byproduct AdoHcy 78. 
 
In agreement with this hypothesis, numerous non-histone proteins such as Dnmt1 (reduction 
in stability), p53 (activation and stabilization), TAF10 (increased affinity for polymerase II), 
estrogen receptor α (activation and stabilization), pRb, p65 and Tat protein of HIV1 are 
methylated by SET7/9 79-87. In addition, a recent study identified up to 90 new non-histone 
target peptides and a strong methylation of free H2A and H2B tails 76. Hence, the targeting of 
SET7/9 to different substrates suggests a low specificity of the enzyme.  
SET7/9 prefers positively charged substrates and methylates the last lysine residue in 
the motif [K>R][S>KYARTPN][Kme] 76. Peptides that do not perfectly match this sequence 
can be methylated to a lesser extent. In the cell, a strong interaction of acceptor proteins with 
the SET7/9 methyltransferase can stimulate the transfer of a methyl group to weak target sites. 
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Therefore, a weaker methylation does not have to imply a lower biological importance 76. 
Serine phosphorylation of histone tails and non-histone proteins inhibits the methylation of 
those proteins by SET7/9 76. This implies a universal crosstalk between phosphorylation and 
SET7/9 induced methylation 88. 
 
4.6 Poly-ADP-Ribosylation 
ADP-ribosylation is a reversible posttranslational modification of proteins. The target amino 
acids in eukaryotes are lysine, arginine, glutamate, aspartate, cysteine, phosphor serine and 
asparagine residues 89. Mono-ADP-ribosylation involves the addition of one ADP-ribose 
moiety to specific amino acids. This unit can then serve as an acceptor for additional 
modifications and thus give rise to linear or branched polymers of ADP-ribose (PAR) and 
thereby lead to a poly-ADP-ribosylated protein 90. In cells, mono-ADP-ribosylation is mainly 
found outside the nucleus and is more common than poly-ADP-ribosylation (PARylation), 
which mostly occurs on nuclear proteins 91,92. 
 ADP-ribosyltransferases (ARTs) attach either a single or multiple ADP-ribose units 
to themselves (= automodification) or to different target proteins. They use nicotinamide 
adenine dinucleotide (NAD+) as a substrate, which is transferred onto specific amino acid 
side chains or attached to pre-existing protein-linked ADP-ribose units under the release of 
nicotinamide as a byproduct 93 (Fig. 7).  
 
 
Figure 7: Synthesis and degradation of PAR on a target protein by ARTD1. ARTD1 induces the polymerization 
of ADP-ribose units from NAD+ molecules on acceptor proteins, which leads to the formation of PAR. PARG 
induces the hydrolysis of the ADP-ribosylation leading to free mono and oligo(ADP-ribose). ADP-ribosyl 
protein lyase releases the last ADP-ribose monomer from the acceptor protein, freeing ADP-3″-deoxypentose-
2″-ulose (ADP-DP). Modified from 94. 
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PAR formation requires three enzyme-catalyzed steps: initiation of mono-ADP-
ribosylation, elongation, and branching of the polymer 95. The chain length is variable and 
can reach up to 400 units in vitro. Long polymers are consecutively branched after a linear 
section of 20 to 50 units of ADP-ribose 96. As mentioned, in vivo the level of PARylation is 
determined by the opposing activities of ARTs and PAR-degrading enzymes. The glycosidic 
bond between two ADP-ribose units can be hydrolyzed by Poly(ADP-ribose) 
glycohydrolases (PARGs) and ADP-ribosyl hydrolases (ARHs) 97,98. In mice, PARG knock 
out leads to embryonic lethality due to the increased PAR accumulation, indicating the 
importance of PARG as the major PAR-degrading factor in cells 99. 
 Modification of proteins by ADP-ribosylation adds negative charge to the acceptor 
protein. In the case of PAR chains, this can be substantial and thus affect the target protein 
structure, enzymatic activity, or interaction with other proteins 100. Different types of 
conserved PAR binding modules interact with PAR in a non-covalent way. This includes a 
PAR binding zinc finger domain 101, macrodomains 102, and a short PAR-binding motif 
consisting of basic and hydrophobic amino acids, which can be found in many DNA 
checkpoint proteins 103. 
 
4.6.1 ADP-Ribosyltransferase Diphtheria Toxin-like (ARTD) Family 
There are three families of mammalian proteins, which catalyze mono- and or poly-
ADP-ribosylation. The sirtuins, NAD+-dependent protein deacetylases 104, the ARTCs 
(formerly ecto-ARTs) with a homology to cholera C2 and C3 toxin 97, and the ARTDs 
(formerly poly(ADP-ribose) polymerases (PARPs)) with sequence homology to bacterial 
diphtheria toxin 105. Among the family of ARTDs are both mono- and poly-ADP-
ribosyltransferases, whereas the other two families are believed to catalyze only mono-ADP-
ribosylation.  
 So far, 18 ARTD proteins have been found in humans 89. The best-studied member of 
the ARTD family is ARTD1, a nuclear, chromatin-associated enzyme, which is responsible 
for around 90% of the cellular PAR generation 106,107. All ARTDs share a highly conserved 
50 amino acid motif within their catalytic domain, which allows the binding of NAD+ 108. An 
evolutionary conserved H-Y-E catalytic triad is responsible for the PARylation activity 89,109. 
For the ADP-ribose chain elongation, the catalytic glutamate residue E988 is needed 110,111, 
and for NAD+ binding the histidine and tyrosine residues are important. ARTD1 to 6 contain 
a complete H-Y-E motif and have putative PARylation activity. Members lacking only the 
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glutamate residue (ARTD8 and 10) have putative mono-ADP-ribosyltransferase activity. 
ARTD9 and 13, which miss the histidine and glutamate residues, are catalytically inactive 109.  
 Most probably, only members of the ARTD family are able to ADP-ribosylate 
histones. ARTD1, ARTD2 and ARTD3 are the only ARTs exclusively found in the nucleus, 
whereas ARTD4, ARTD5, ARTD6, ARTD9 and ARTD10 are localized in the nucleus and 
the cytoplasm 105. ARTD1 and 3 are known to poly-ADP-ribosylate individual histones, 
while ARTD10 only results in mono-ADP-ribosylated histones 109,112,113. Because only a few 
percent of the total histones are ADP-ribosylated, it is difficult to detect and identify specific 
acceptor sites 114. However, all core histones and the linker histone H1 are potential acceptors 
of ADP-ribose and can for example be modified during or shortly after their synthesis in the 
cytoplasm, during transport into the nucleus, while bound to chaperons, or after their 
integration into chromatin 90.  
Based on in vitro and in vivo results, chromatin-associated histone H1 is the major PAR 
acceptor, followed by H2B, whereas the rest of the core histones are weakly modified 115,116. 
A PAR chain length of up to 15 ADP-ribose units has been seen for histone H1 117, whereas 
core histone are modified with shorter oligomers 118.  
 
4.7 ADP-Ribosyltransferase Diphtheria Toxin-like 1 (ARTD1)  
ARTD1 is a 113 kDa protein, formed by 1014 amino acids, and holds three main 
functional units. The N-terminal DNA-binding domain (DBD) contains three zinc finger 
domains (ZF I, ZF II and ZBD III) for the DNA-dependent activation and a nuclear 
localization sequence (NLS). The central automodification domain (AMD) comprises three 
confirmed modification sites (K498, K521, K524) 95 and a BRCT (BRCA1 C-terminus) motif 
for protein-protein interaction, which is found in various DNA damage response proteins. 
The C-terminal catalytic domain includes a W-G-R motif and a NAD+ binding fold for the 
enzymatic activity of ARTD1 (Fig. 8). 
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Figure 8: Structural features of ARTD1. DBD: DNA binding domain with zinc fingers ZFI, ZFII, a nuclear 
localization signal (NLS) and a zinc binding domain (ZBD). AMD: automodification domain with the BRCA1 
C-terminus (BRCT). CAT: catalytic domain with the WGR motif and the NAD+ binding domain. 
 
ARTD1 is involved in cellular processes such as the DNA damage response, cell 
cycle regulation, gene expression, differentiation and aging. It modifies nuclear proteins 
including core and linker histones, DNA repair proteins and transcription factors, but first 
and foremost ARTD1 targets itself. Under normal conditions, the activity of ARTD1 is low, 
but as soon as the enzyme binds to DNA strand breaks, the activity is greatly increased and 
PAR levels rise (up to 10 to 500 fold) 119. 
 As mentioned previously, ARTD1 plays a critical role in many physiological and 
pathophysiological processes. ADP-ribosylation by ARTD1 affects inter- and intracellular 
signaling, cell cycle regulation, chromatin remodeling, DNA replication, transcription, DNA 
repair, somatic recombination, regulation of telomere length, inflammation and cell death via 
apoptosis or necrosis 105,120. The deletion of ARTD1 renders mice hypersensitive to ionizing 
radiation and thus cells are more sensitive to alkylating agents. However, these mice are 
viable and their phenotype supports the importance of ARTD1 for the maintenance of 
genomic integrity 119,121-123. 
The modification of core and linker histones by the enzymatic activity of ARTD1 
induces decondensation of higher order chromatin structures 107,124,125. However, there is 
contradictory data regarding the compactness of chromatin. In vivo condensation and in vitro 
decondensation was reported after ARTD1 treatment 116,126,127. Further, ARTD1 might 
function as a substitute for H1, as the enzyme was concentrated at actively transcribed gene 
promoters and H1 showed a reciprocal chromatin binding pattern to ARTD1. Upon ARTD1 
depletion, H1 was also enriched at ARTD1-regulated genes 128. Nuclear factor kappa B (NF-
κB) regulates transcription of inflammatory and cell survival genes, where ARTD1 co-
activator function is also involved 129. Upon extracellular inflammatory stimuli such as LPS 
or TNFα, a synergistic co-activation of NF-κB dependent gene expression through ARTD1, 
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the acetyltransferase p300, the arginine methyltransferase 1 (CARM1) and the protein 
arginine methyltransferase 1 (PRMT1) takes place 129,130.  
 The enzymatic activity of ARTD1 is allosterically induced upon binding to single and 
double strand breaks, cruciform, crossovers and supercoils 131. Because of this and of the 
rapid recruitment to sites of DNA damage in vivo, which is essential for accumulation of 
repair factors like XRCC and the MRN complex 132,133, ARTD1 was mainly regarded as a 
DNA damage response protein. Also, many DNA repair factors have PAR-binding domains 
and are recruited to DNA damage sites in a PAR-dependent manner 101,103,127,134. Hence, 
ARTD1 and PAR are thought to play an important role in various DNA repair pathways, 
particularly in base excision repair 135-137. Nevertheless, ARTD1 seems to be redundant for 
DNA repair under normal physiological conditions, as DNA repair pathways are effective in 
cells lacking ARTD1 138-140 and knockout mice are viable, fertile and without increased tumor 
risk 141.  
 Oxidative stress induces hyperactivation of ARTD1, which results in a depletion of 
cellular NAD+ and ATP levels and thereby induces cell death 142,143. Hyperactivation of the 
nuclear ARTD1 activity leads to accumulation of PAR in the cytosol. Cytoplasmic PAR then 
binds the apoptosis inducing factor (AIF). Due to the PAR binding, AIF is subsequently 
released from the mitochondrial membrane and relocalized to the nucleus, where it induces 
DNA fragmentation and caspase-independent cell death 144. During apoptosis, ARTD1 is 
cleaved and thus inactivated by caspases to prevent a deleterious activation of the enzyme in 
response to the DNA fragmentation. This should preserve the cellular ATP levels, which is 
needed for apoptosis 145. Nevertheless, knock in mice with a caspase-resistant, non-cleavable 
ARTD1 (D214N) develop normally, which suggests that ARTD1 cleavage is not an absolute 
requirement for apoptosis 146. 
 
4.7.1 Posttranslational Modifications of ARTD1 
NAD+-dependent automodification of ARTD1 within the DBD and AMD is one of its 
most important post-translational modifications 95. Interaction with DNA activates the 
enzymatic activity of ARTD1. Auto-PARylation leads to repulsion from the DNA due to the 
negative charge of the modified ARTD1 and the DNA 95. This negative feedback loop 
reduces the overproduction of PAR. 
Also, trans-modification of ARTD1 takes place. ARTD1 is phosphorylated by the 
mitogen-activated protein kinases ERK1/2 at the S372 and T373 sites, which enhances the 
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DNA damage induced enzymatic activity of ARTD1 147. Phosphorylation by JNK1 leads to 
sustained ARTD1 activation during H2O2 exposure 148, AMPK increases ARTD1 activity 149, 
whereas protein kinase C decreases ARTD1 DNA binding and enzymatic activity 150. 
Another modification is acetylation by p300/CBP at five different lysine residues (K498, 
K505, K508, K521, K524), which allows interaction with p50 and the co-activator function 
for NF-κB-dependent gene expression 151. 
Furthermore, ARTD1 is a target of covalent addition of polypeptides such as ubiquitin 
and small ubiquitin-like modifier (SUMO). SUMO E3 ligase PIASγ modifies ARTD1 at 
K486 and thereby interferes with its co-activator function in HIF1-dependent gene 
expression 152. 
Interestingly, various post-translational modifications target the same or neighboring 
amino acids within the AMD, which allows crosstalk between the different modifications. 
For instance, automodification of ARTD1 is likely reduced by acetylation, as it modifies 
three amino acids that are important for PARylation of the enzyme. 
 
4.8 PARP Inhibitors 
Cell lines deficient in homologous recombination (HR), which is an essential, error-
free DSB repair mechanism, display high lethality when treated with pharmacological ARTD 
inhibitors (PARP inhibitors) 153,154. Tumor suppressor proteins BRCA1 and BRCA2 are 
required for HR and are mutated in many cases of heritable breast, ovarian and prostate 
cancer. Therefore, the treatment of these and other types of cancer with PARP inhibitors, 
alone or in combination with chemotherapy, is presently tested in clinical trials. The 
hypothesis is that ARTD1 inhibition should slow down the repair of single strand breaks. 
Endogenously generated SSBs would add up and then be altered into DSBs during 
replication. HR deficient cancer cells would not be able to repair these defects and die. 
However there have to be other mechanisms that contribute to the lethal effect of PARP 
inhibitors, as different studies did not detect an increase in DNA strand breaks in treated cells 
155,156. It is believed that the negative influence of PARP inhibitors on NF-κB-dependent anti-
apoptotic gene expression could be one of these factors 157,158. 
There are other pathophysiological settings, where the clinical relevance of PARP 
inhibitors is further elucidated. During cerebral ischemia/reperfusion in patients suffering a 
stroke or in inflammatory disorders, the suppression of an ARTD1 hyperactivation could lead 
to a better outcome 159,160. 
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Most PARP inhibitors are unspecific nicotinamide analogs and thus target not only 
ARTD1 but also other NAD+ dependent enzymes including other ARTD family members. 
One of the first substances that were used to inhibit ARTD1 in vivo and in vitro was 3-
aminobenzamide (3-AB). However, its potency and specificity were too low for therapeutic 
uses. Nowadays, several newly developed PARP inhibitors with increased potency and less 
off-target effects are in clinical trails 161. Olaparip (AstraZeneca) and ABT-888 (Abott), 
which already passed numerous phase II trials as treatments against different kinds of cancer, 
either alone or in combination with chemotherapy, are two of them. 
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5 Aim of the Thesis 
 
SET7/9 mono-methylates H3K4 as well as many non-histone proteins and controls 
numerous DNA damage response proteins such as p53, pRb and E2F1. We thus investigated 
whether the linker histone H1 is modified by SET7/9 and which amino acids are serving as 
methylation acceptor sites. 
ARTD1 and the linker histone H1, two chromatin-associated proteins, affect many 
DNA-related processes. The second aim of this thesis was thus to investigate if and where H1 
was modified by ARTD1 and how a possible ADP-ribosylation would affect SET7/9-
mediated methylation. 
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6 Material und Methods 
6.1 DNA based Methods 
6.1.1 PCR: Site directed Mutagenesis 
To create single lysine mutants in the H1.4 fragments 2 and 3, site directed 
mutagenesis was performed. Forward and reverse primers were designed to mutate the 
nucleotide sequence of specific lysines into the code for an arginine (AAG to AGG or AGA 
to AGG). Upstream and downstream of the mutation at least 12 correct nucleotides were 
attached to the primer to assure the correct binding. In the PCR reaction (100 ng template 
DNA, 1 µM of each primer, 200 µM of each nucleotide (dNTPs), 1x concentration of 10x Pfu 
buffer (Promega) and 1 unit of Pfu-polymerase (Promega), in 25 µl total volume), the 
plasmid served as template and was afterwards digested with DPN1 (NEB, according to 
manufacturer’s protocol) to remove the non-amplified DNA. The remaining DNA was 
transformed into bacteria. The PCR program included the following steps: 2 min at 95°C, 
followed by 25 cycles of 30 s at 95°C, 1 min at 55°C, 14 min at 68°C, and a last step with 7 
min at 68°C. Using a template with a single or double mutant in the reaction allowed to 
generate double and triple mutants, respectively.  
 
6.1.2 PCR: Overlapping PCR 
To create the cluster mutations in fragment 2 and 3, four different primers were 
designed for each cluster mutation. An outer forward primer and an outer reverse primer 
were designed to amplify the whole fragment, together with a reverse as well as a forward 
cluster primer, which encoded the desired mutation on the 5’-end (lysines mutated to arginine, 
AAG to AGG or AGA to AGG) and at least 18 nucleotides at the 3’-end, which allowed 
proper binding to the template. During the first PCR, two products were separately amplified 
using one flanking primer (e.g., outer forward/outer reverse) and one mutation primer (e.g., 
cluster reverse/cluster forward). The first PCR (100 ng template DNA, 1 µM of each primer, 
200 µM of each nucleotide (dNTPs), 1x concentration of 10x Phusion buffer HF (NEB) and 1 
unit of Phusion-polymerase (NEB), in 25 µl total volume) included following steps: 3 min at 
98°C, followed by 25 cycles of 15 s at 98°C, 30 s at 55°C, 15 s at 75°C, and a last step with 7 
min at 75°C. The separate products were then used together in a second overlapping PCR 
reaction as templates without primers. Due to the complementarity of the templates at the 
mutation site, the PCR fragments were initially combined in the first five cycles. After these 
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cycles, the flanking primers were added as described below to generate the desired full length 
PCR product. The second PCR (1 µl of both products from the first PCR, 1 µM of each 
flanking primer, 200 µM of each nucleotide (dNTPs), 1x concentration of 10x Phusion buffer 
HF (NEB) and 1 unit of Phusion-polymerase (NEB), in 50 µl total volume) included 
following steps: 3 min at 98°C, followed by 5 cycles of 15 s at 98°C, 30 s at 60°C, 20 min at 
72°C, and a step with 3 min at 60°C, where the flanking primers were added, then the steps in 
the first cycle were repeated 25 times and a last step with 7 min at 72°C. The products were 
then loaded on a 1% agarose gel (Agarose from Promega) and separated with 90V in 1x TAE 
buffer (40 mM Tris acetate, 1 mM EDTA, 0,1% (v/v) acetic acid). The DNA from the PCR 
was subsequently cut out from the gel and isolated (according to 5.1.4). 
 
6.1.3 Primers used 
OTM Primer name 5'-Sequence 
   
1315 hH1.4_BamHI_for GATCGGATCCATGTCCGAGACTGCGCCTG 
1316 hH1.4_fl_XhoI_rev GATCCTCGAGCTACTTTTTCTTGGCTGCCG 
1317 hH1.4_a113_XhoI_rev GATCCTCGAGCTAAGAGGCCGCCTTCTTGTTGAG 
1318 hH1.4_a189_XhoI_rev GATCCTCGAGCTACGCTGGGCTCTTGGGCGC 
1319 hH1.4_a156_XhoI_rev GATCCTCGAGCTACTTTGGGGTCTTCTTGGCG  
1330 hH1.4_aa144_XhoI_rev GATCCTCGAGCTACGCCCCCGTCGCCTTCTTG 
1331 hH1.4_aa114_BamHI_for AGCTGGATCCGGGGAAGCCAAGCCTAAGG 
1332 hH1.4_aa145_BamHI_for AGCTGGATCCGCCACCCCCAAGAAGAGCG 
1333 hH1.4_aa190_BamHI_for AGCTGGATCCAAGGCCAAAGCAGTTAAACCC 
1443 hH1.4_aa113_XbaI_rev GATCTCTAGACTAAGAGGCCGCCTTCTTGTTGAG 
1444 hH1.4_fl_XbaI_rev GATCTCTAGACTACTTTTTCTTGGCTGCCG 
1445 hH1.4 Cluster1 for AGGGCGAGGAGGCCGGCTGCAGCTGCTGG 
1446 hH1.4 Cluster1 rev CCTCCTCGCCCTCTTTGGGGTCTTCTTGG 
1447 hH1.4 Cluster2 for AGAAGAGCGAGAAGCCCGAGAAGGGCGAGAGCAGCCAAGCCAAAAAAGG 
1448 hH1.4 Cluster2 rev TCTCGCCCTTCTCGGGCTTCTCGCTCTTCTGGCTCCAGCAGCTGCAGC 
1449 hH1.4 Cluster3 for AGGCCAAGAAGGGCGCCCAGGAGCCCAGCGAAGGCCAAAGC 
1450 hH1.4 Cluster3 rev AGGCCAAGAAGGGCGCCCAGGAGCCCAGCGAAGGCCAAAGC 
1451 hH1.4 Cluster4 for AGGGCCAGAGCAGTTAGACCCAGGGCGGCTAAACCAAAGACC 
1452 hH1.4 Cluster4 rev CCTGGGTCTAACTGCTCTGGCCCTCGCTGGGCTCTTGGGCGC 
1453 hH1.4 Cluster5 for AGACCAAGGACCGCCAGGCCCAGGGCAGCCAAGCCAAAGAAGG 
1454 hH1.4 Cluster5 rev CCTGGGCCTGGCGGTCCTTGGTCTAGCCGCCTTGGGTTTAACTGC 
1455 hH1.4 Cluster6 for AGGCCAAGGAGGGCGGCAGCCAGGAGAAGGTAGCTCGAGCGGCCGCATCG 
1456 hH1.4 Cluster6 rev CCTTCTCCTGGCTGCCGCCCTCCTTGGCCTGGCTGCCTTGGGCTTGGCGG 
1457 Outer ScaI for TTGATAAGTACTTGAAATCCAGCAAG 
1458 Outer ScaI rev TCTGTGACTGGTGAGTACTCAACC 
1473 hH1.4 Cluster4 rev new CCTGGGTCTAACTGCTCTGGCCCTGGATCCAGATCCGCCCG 
1474 hH1.4 Cluster1a for AGGAGGAGCGCCAGGAGGACCCCAAGGAGGGCGAAGAAGCCGGCTGC 
1475 hH1.4 Cluster1a rev CCTCCTTGGGGTCCTCCTGGCGCTCCTCCTGGGGGTGGCGGATCCAG 
1489 hH1.4 K157R for CCAAAGAAGGCGAGGAAGCCGGCTGC 
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1490 hH1.4 K157R rev GCAGCCGGCTTCCTCGCCTTCTTTGG 
1491 hH1.4 K171R for GAGCCAAAAAAGCGAGAAGCCCGAAAAAGGC  
1492 hH1.4 K171R rev GCCTTTTTCGGGCTTCTCGCTTTTTTGGCTC  
1493 hH1.4 K177R for CCGAAAAAGGCGAGAGCAGCCAAGCC 
1494 hH1.4 K177R rev GGCTTGGCTGCTCTCGCCTTTTTCGG 
1495 hH1.4 K192R for CTGGATCCAAGGCCAGAGCAGTTAAACCC  
1496 hH1.4 K192R rev GGGTTTAACTGCTCTGGCCTTGGATCCAG  
1497 hH1.4 K197R for GCAGTTAAACCCAGGGCGGCTAAACCAAAG   
1498 hH1.4 K197R rev CTTTGGTTTAGCCGCCCTGGGTTTAACTGC   
1499 hH1.4 K212R for GCAGCCAAGCCAAGGAAGGCGGCAGC    
1500 hH1.4 K212R rev GCTGCCGCCTTCCTTGGCTTGGCTGC    
1501 hH1.4 K219R for GGCAGCCAAGAAAAGGTAGCTCGAGCGG     
1502 hH1.4 K219R rev CCGCTCGAGCTACCTTTTCTTGGCTGCC 
1511 hH1.4 K192R (fl) for GAGCCCAGCGAAGGCCAGAGCAGTTAAACCC 
1512 hH1.4 K192R (fl) rev GGGTTTAACTGCTCTGGCCTTCGCTGGGCTC 
 
6.1.4 Agarose Gel Extraction of DNA 
Digested DNA and PCR products with the correct length were cut out from the gel 
(Agarose from Promega Corporation). Per 100 mg gel, 200 µl of NT-binding-buffer 
(MACHEREY-NAGEL, Switzerland) was added to dissolve the agarose gel and to 
equilibrate the purification columns. The sample was then heated to 50°C and mixed until the 
gel was solubilized. This solution was transferred onto a NucleoSpin column (MACHEREY-
NAGEL, Switzerland) and centrifuged for 1 minute at 11000 rpm (12900 rcf) to bind the 
DNA to the silica-matrix of the column. The column was washed using 600 µl NT3 washing 
buffer (MACHEREY-NAGEL, Switzerland) and the centrifugation step was repeated (1 min, 
11000 rpm, 12900 rcf). The washing buffer was discarded and the column dried by a 
2 minute centrifugation step at 11000 rpm (12900 rcf). Then, the column was placed in a 
fresh Eppendorf tube and 30 µl sterile ddH2O was added to the column. After 2 minutes of 
incubation at room temperature, the DNA was eluted from the column by another 
centrifugation step at 11000 rpm (12900 rcf) for 1 minute. 
 
6.1.5 Restriction Endonuclease Digest  
Restriction endonuclease digests were performed to prepare the ends of the amplified 
DNA fragments for cloning. DNAs (vector and insert) were digested with a single 
endonuclease or with two restriction enzymes simultaneously to generate the product ends of 
interest. All enzymes were purchased from New England Biolabs (NEB) and used according 
to NEB’s protocols. 
Posttranslational Modification of Histone 1.4 by SET7/9 and ARTD1 Material und Methods 
 
  32 
 
 
6.1.6 Ligation of DNA Fragments into a Vector 
After the restriction digest, PCR products and the vector DNA were separately 
purified with NucleoSpin columns (as described in 5.1.4). For the ligation reaction, 
approximately 50 ng of linearized vector (pGEX-6PI, pEGFP-C1, pET28a), insert DNA in a 
molar ratio of 1:3 of vector to insert, 1µl of 10x T4-DNA-Ligase Buffer (Fermentas), and 
1 Weiss Unit of T4-Ligase (Fermentas) were used. The ligation mix was incubated overnight 
at 16°C and inactivated at 65°C for 20 min the next day. 
 
6.1.7 Small-scale Plasmid Isolation (Miniprep) 
3 ml of an XL-10 E. coli overnight culture were grown under selection conditions and 
centrifuged for 5 minutes at 5000 rpm (2700 rcf). 300 µl RES-buffer (MARCHEREY-
NAGEL, Switzerland) was used to resuspend the pellet. Then, 300 µl LYS-buffer 
(MARCHEREY-NAGEL, Switzerland) was added to lyse the bacteria. The samples were 
tilted 2-3 times and incubated 5 minutes at room temperature. Subsequently, 400 µl NEU-
buffer (MARCHEREY-NAGEL, Switzerland) was added to stop the lysis. The samples were 
tilted twice, incubated on ice for 10 minutes, and centrifuged for 20 minutes at 14000 rpm 
(20800 rcf, 4°C). The supernatant, containing the extra chromosomal DNA, was transferred 
into a fresh tube and 700 µl isopropanol (100%, Sigma-Aldrich) was added to precipitate the 
DNA. Next, the samples were tilted and incubated for 10 minutes on ice. After centrifugation 
for 10 minutes at 14000 rpm (20800 rcf, 4°C), the supernatant was discarded and 200 µl of 
ice cold ethanol (70%) was added to wash the precipitated DNA. The DNA was incubated on 
ice for another 5 minutes, followed by centrifugation for 5 minutes at 14000 rpm (20800 rcf, 
4°C). After that, the ethanol was discarded and the pellet was air-dried for 10 minutes at 
room temperature. The pellet containing the DNA was resuspended by adding 20 µl of sterile 
H2O and gentle shaking for 20 minutes at room temperature. 
 
6.2 Microbiological Methods 
6.2.1 Transformation of Chemo-competent E. coli 
Approximately 100 ng plasmid DNA and 90-120 µl competent E. coli, strain XL-10 
for plasmid amplification or BL-21 for protein production, were incubated on ice for 10 
minutes. Then, bacteria were heat shocked by exposing the mixture to 42°C for 45 seconds. 
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Subsequently, the samples were placed again on ice for 10 minutes. To allow the bacteria to 
recover and to express the selection markers, 1 ml of LB medium was added and the tubes 
were incubated while shaking for 60 minutes at 37°C. Samples were centrifuged for 1 minute 
at 11000 rpm (12900 rcf) to pellet the bacteria, the supernatant was discarded, the pellet 
resuspended in 100 µl LB medium and the cell suspension plated on a LB Agar-plate 
containing 50 µg/ml ampicillin or kanamycin, depending on the resistance marker of the 
plasmid. The plate was incubated overnight at 37°C. The next day, bacterial colonies were 
picked and inoculated into 3 ml LB-medium with 50 µg/ml antibiotics overnight at 37°C.  
 
6.2.2 Expression of GST/His-tagged Histones in Bacteria 
Plasmid-DNA was transformed into competent E. coli strain BL-21, according to 
5.2.1. E. coli cells were grown at 37°C overnight in 20 ml LB medium containing 50 µg/ml 
ampicillin or kanamycin, depending on the plasmid’s resistance marker. The next day, 5 ml 
of the bacterial culture was transferred into 120 ml LB medium containing antibiotics and 
grown at 37°C to an OD600= 0.6. Addition of 1 mM IPTG induced the expression of the 
GST/His protein. After 4 hours incubation at 37°C, bacteria were centrifuged in a Sorvall RC 
5C Plus centrifuge with a SLA-3000 rotor at 4000 rpm (2702 rcf) for 15 minutes at 4°C. The 
supernatant was discarded and the pellet was stored at -80°C until the purification was 
continued (see 5.3.1). 
 
6.3 Protein based Methods 
6.3.1 Purification of His/GST-tagged H1.4 Constructs 
Tagged histone constructs were purified from frozen bacteria. The frozen pellets were 
thawed on ice and resuspended in 20 ml binding buffer (BB) (for content see below). Next, 
the solution was passed three times through a French® pressure cell press (SIM-AMINCO) 
with a maximum of 1500 psi and subsequently centrifuged in a Sorvall RC 5C Plus 
centrifuge with a SS-34 rotor for 30 minutes at 4°C and at 18000 rpm (38729 rcf). 
Meanwhile, 125-200 µl of a 50% (v/v) suspension Ni-Sepharose 6 Fast Flow beads 
(Amersham Bioscience) for His-tagged proteins, or Glutathione Sepharose 4B beads (GE 
Healthcare) for GST-tagged proteins, were equilibrated. The beads were washed twice with 
1 ml BB and centrifuged at 2400 rcf for 1 minute after each washing step. Afterwards, the 
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cleared cell lysate (from above) was bound to the beads in a 50 ml falcon tube for 2 hours at 
4°C while rolling. 
The H1.2 cluster mutants were purified in a special manner. The bacterial pellets were 
initially resuspended in 15 ml EBC-buffer (for content see below) and processed as described 
above. After the first centrifugation, the pellet was resuspended in 500 µl 5% (v/v) perchloric 
acid and incubated in a Eppendorf tube for 2 hours at 4°C while rolling. Next, the suspension 
was centrifuged for 10 minutes at 4°C and 20800 rcf. After transferring the supernatant into a 
15 ml falcon tube, 200 µl 3M Tris pH 9.5 were added. While shaking gently, 13,7 ml BB 
were slowly added and then the proteins were bound to the equilibrated beads for 2 hours at 
4°C while shaking. 
Later, all beads were collected by centrifugation (Hettich, 251 rcf, 5 minutes, 4°C) 
and were washed three times with 10 ml washing buffer (WB) (for content see below) for 10 
minutes. The beads were transferred into a 1,5 ml Eppendorf tube and washed with 1 ml 
elution buffer (EB) (for content see below), without imidazole for His-tagged proteins or 
without glutathione for GST-tagged protein, and centrifuged at 2400 rcf for 1 minute at 4°C. 
Next, the purified proteins were eluted by twice adding 200-800 µl elution buffer with 
imidazole or with glutathione for 30 minutes at 4°C while rolling. Each time, the beads were 
collected by centrifugation (2400 rcf, 1 minute, 4°C) and the supernatant, containing the 
eluted proteins, was transferred into a fresh Eppendorf tube. Lastly, the eluted proteins were 
dialyzed overnight in 1 liter of dialysis buffer (for content see below) and a molecular porous 
membrane (MWCO: 6-8.000) (SPECTRA/POR®). 
Composition of buffers used for the purification of GST-tagged proteins:  
BB pH 7.3: 0.05 M Tris-HCl pH 7.4, 0.2 M NaCl, 0.1% (v/v) NP-40, 5% (v/v) glycerol, 
1 mM DTT, 2 mM PMSF and 1 µl/ml pepstatin, bestatin and leupeptin.  
WB pH 7.3: 0.05 M Tris-HCl pH 7.4, 0.5 M NaCl, 0.1% (v/v) NP-40, 5% (v/v) glycerol, 
1 mM DTT, 2 mM PMSF and 1 µl/ml pepstatin, bestatin and leupeptin.  
EB pH 8: 0.05 M Tris-HCl pH 7.4, 0.05 M NaCl, 0.04 M glutathione, 5% (v/v) glycerol, 
1 mM DTT, 2 mM PMSF and 1 µl/ml pepstatin, bestatin and leupeptin. 
Dialysis Buffer pH 7.4: 0.05 M Tris-HCl pH 7.4, 0.05 M NaCl, 20% (v/v) glycerol, 1 mM 
DTT, 2 mM PMSF and 1 µl/ml pepstatin, bestatin and leupeptin. 
Composition of buffers used for the purification of GST-tagged proteins:  
EBC: 0.05 M Tris-HCl pH 8, 0.12 M NaCl, 0.5% (v/v) NP-40, 5 mM DDT, 1 mM PMSF. 
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BB pH 7.4: 0.05 Tris-HCl pH 7.5, 0.5 M NaCl, 1% (v/v) triton, 5% (v/v) glycerol, 15 mM 
imidazole, 2 mM β-ME, 2 mM PMSF and 1 µl/ml pepstatin, bestatin and leupeptin 
WB pH 7.4: 0.05 M Tris-HCl pH 7.5, 0.3 M NaCl, 1% (v/v) triton, 5% (v/v) glycerol, 15 mM 
imidazol, 2 mM β-ME, 2 mM PMSF and 1 µl/ml pepstatin, bestatin and leupeptin 
EB pH 7.4: 0.05 M Tris-HCl pH 7.5, 0.05 M NaCl, 5% (v/v) glycerol, 0.5 M imidazol, 2 mM 
β-ME, 2 mM PMSF and 1 µl/ml pepstatin, bestatin and leupeptin. 
Dialysis Buffer pH 7.4: 0.05 M Tris-HCl pH 7.4, 0.05 M NaCl, 20% (v/v) glycerol, 1 mM 
DTT, 2 mM PMSF and 1 µl/ml pepstatin, bestatin and leupeptin 
 
6.3.2 Bradford Protein Concentration Measurement 
To determine protein concentrations, the Bradford assay was performed. 5x BIO-
RAD solution (BIO-RAD Protein assay, Bio-Rad Laboratories GmbH) was diluted to 1x 
concentration with ddH2O. 5-15 µl of protein extract or 20 µl of BSA standard solutions 
(0.190 mg/ml, 0.328 mg/ml, 0.492 mg/ml and 0.643 mg/ml) were added to 1 ml of the 1x 
BIO-RAD solution. The absorbance was measured at 595 nm in a spectrometer and the 
protein concentrations were calculated based on the BSA standard curve.  
 
6.3.3 Methylation Assay 
1 µg purified protein was incubated with 1 µg SET7/9 and 30 nCi SAM or 20 mM 
cold SAM in methylation buffer (50 mM NaCl, 50 mM Tris pH 8 (pH 7.2 or pH 9 in 
experiments with H1.2), 10% (v/v) glycerol, 1 mM PMSF) in a total volume of 25 µl for 1 
hour or 15 minutes at 30°C. The reaction was stopped by adding 3 µl of 10x SDS-sample 
buffer (600 mM Tris-HCl (pH 6.8), 20% (w/v) Na-dodecylsulfate, 20% (v/v) glycerol, 0.05% 
(w/v) bromphenol blue, 20% (v/v) mercaptoethanol, 25 mM DTT). The samples were 
subsequently boiled for 5 minutes at 95°C, followed by protein separation using a SDS-
PAGE (as described in 5.3.6). The methylation assay was analyzed either by autoradiography 
or western blot.  
 
6.3.4 PARylation Assay 
1 µg purified protein was incubated with 10 pmol ARTD1 or ARTD10 in the presence 
or absence of 5 pmol activating EcoRI-linker DNA and 0.16 mM 32P-NAD+ or 10 mM cold 
NAD+ in PARylation buffer (50 mM NaCl, 50 mM Tris pH 8, 4 mM MgCl2, 250 µM DTT, 
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1 mg/ml pepstatin, 1 mg/ml bestatin, 1 mg/ml leupeptin) in a total volume of 25 µl for 10 
minutes and at 30°C. The reaction was stopped by adding 3 µl of 10x SDS-sample buffer 
(600 mM Tris-HCl (pH 6.8), 20% (w/v) Na-dodecylsulfate, 20% (v/v) glycerol, 0.05% (w/v) 
bromphenol blue, 20% (v/v) mercaptoethanol, 25 mM DTT). The samples were subsequently 
boiled for 5 minutes at 95°C, followed by protein separation using SDS-PAGE (as described 
in 5.3.6). The PARylation assay was analyzed either by autoradiography or western blot. 
 
6.3.5 Sequential ADP-Ribosylation and Methylation Assay 
1 µg purified protein was incubated with 10 pmol ARTD1 in the presence of 5 pmol 
activating EcoRI-linker DNA and 160 µM NAD+ in PARylation buffer (50 mM NaCl, 
50 mM Tris pH 8, 4 mM MgCl2, 250 µM DTT, 1 mg/ml pepstatin, 1mg/ml bestatin, 1mg/ml 
leupeptin) in a total volume of 25 µl for 15 minutes and at 30°C. 0.2 mM PJ-34 was used to 
inhibit PARylation by ARTD1 either before ADP-ribosylation or afterwards, always with 
5 minutes incubation time. 1 µg SET7/9 and 0.03 µCi 14C-SAM was then added to start the 
methylation (1 hour at 30°C). The reaction was stopped by adding 3 µl of 10x SDS-sample 
buffer (600 mM Tris-HCl (pH 6.8), 20% (w/v) Na-dodecylsulfate, 20% (v/v) glycerol, 0.05% 
(w/v) bromphenol blue, 20% (v/v) mercaptoethanol, 25 mM DTT). The samples were 
subsequently boiled for 5 minutes at 95°C, followed by protein separation using SDS-PAGE 
(as described in 5.3.6). The assays were analyzed by autoradiography. 
 
6.3.6 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
The SDS-PAGE is used to separate proteins based on their molecular weight. Initially, 
a glass and a teflon plate (10 x 8.5 cm) were cleaned with Ethanol (70%) and laid on top of 
each other, separated by two spacers (10 x 0.15 cm). After assembling, the plates were placed 
into a gel preparation unit and 6 ml of separation gel solution was poured between the two 
plates (15% SDS-PAGE: 3 ml ddH2O, 2 ml Solution B (1.5 M Tris-HCl pH 8.8, 0.4% (w/v) 
Na-dodecyl sulfate), 3 ml Acrylamide (Acrylamide-Bis solution (37.5:1), 40% (w/v), 
SERVA Electrophoresis GmbH), 80 µl APS (10%), 8 µl TEMED). Immediately after filling 
the chamber, the gel was overlaid with 1 ml of H2O to obtain a sharp border of the gel. After 
polymerization (10 to 20 minutes), the water was replaced by 3 ml of stacking gel solution 
(3 ml of 4% (v/v) stacking solution (65 ml ddH2O, 25 ml Solution C (0,5 M Tris-HCl pH 6.8, 
0.4% (w/v) Na-dodecyl sulfate and a tip of Bromphenol blue), 10 ml of 40% (w/v) 
Posttranslational Modification of Histone 1.4 by SET7/9 and ARTD1 Material und Methods 
 
  37 
 
Acrylamide), 30 µl APS (10%), 3 µl TEMED). Before polymerization, a comb containing 10 
or 15 flaps was stuck into the stacking gel solution to generate the sample pockets. SDS-gels 
were either directly used 2 hours after pouring or stored at 4°C overnight. To run the gel, the 
comb was removed and the gel was placed into a running unit filled with 1x SDS running 
buffer (25 mM Tris base, 200 mM Glycine, 0.1% (w/v) Na-dodecyl sulfate). The sample 
pockets were rinsed with 1x SDS running buffer. Into one pocket, 3 µl of a pre-stained 
protein ladder (PageRuler™) as a marker with distinct molecular weights was loaded. The 
other pockets were loaded with different samples and run for 20 minutes at 70V, allowing 
proteins to stack and reach the beginning of the separation gel. Then, the voltage was raised 
to 120V until the sample buffer reached the end of the gel (1-2 hours). Finally, the gel was 
disassembled and either stained or blotted (as described in 5.3.7). For staining, the gel was 
soaked in Coomassie staining solution (0.25% (w/v) Coomassieblue R250, 40% (v/v) 
Methanol, 10% (v/v) Acetic acid) for at least 20 minutes. Destaining was performed with 
Fast Destain (12% (v/v) Methanol, 10% (v/v) Acetic acid) and the stained gel was dried in a 
gel dryer (Model 583, Bio Rad) at 70°C for 3 hours.  
Gels containing radioactively marked proteins (14C-SAM) were then exposed to a film 
(Typox TX-RP medical X-ray film, Raymed Imaging AG, Krauchthal), which was developed 
(Optimax, Raymed Imaging AG, Krauchtal) after 1-3 days of exposure. 
 
6.3.7 Western Blot Analysis 
After SDS-PAGE, proteins were transferred to a nitrocellulose membrane to 
specifically detect proteins or posttranslational modifications by western blotting. A western 
blot unit was assembled in a plastic frame in the following order: one wetted sponge, 3 pre-
wetted Whatman papers, one PVDF membrane (Millipore, pore size 0.45 µm, first activated 
in 100% ethanol), the SDS-gel, 3 pre-wetted Whatman papers and one wetted sponge and 
subsequently put with an ice bloc into a western blot chamber filled with 1x transfer buffer 
(20% (v/v) methanol, 70% ddH2O, 10% (v/v) 10x transfer buffer (25 mmol/l Tris-base, 
192 mmol/l glycine, dissolved in ddH2O)). Blotting was performed overnight at 32V and 4°C 
and the voltage was increased to 100V for the last 1 hour before processing the membrane. 
To confirm a successful blotting, the membrane was stained with Ponceau red (1% Ponceau 
S, 0.1% (v/v) acetic acid) and destained with deionized water. To avoid unspecific binding of 
the antibody, each membrane was incubated with 5 ml blocking solution for 1 hour on a 
shaker at room temperature. The blocking solution consisted of 5% skim milk or 3% BSA 
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(bovine serum albumin) in TBS-T (10 mmol/l Tris HCl pH 7.5,150 mmol NaCl, ddH2O, 
0.1% (v/v) tween 20) depending on the primary antibody. After blocking, the membrane was 
incubated with the primary antibody (anti-meARTD1, rabbit, 1:5000, Abcam or anti-PAR, 
rabbit, 1:3000, BD) in 1% skim milk or 3% BSA dissolved in TBS-T for 2 hours. After three 
washes with 5 ml TBS-T for 10 minutes each, the membrane was incubated with the 
secondary antibody in the presence of 1% skim milk or 3% BSA for 1 hour on a shaker at 
room temperature. The selection of the secondary antibody depended on the primary 
antibody (anti-rabbit or anti-mouse). At the end, the blot was washed again 3 times with 5 ml 
TBS-T for 10 minutes and analyzed with an Odyssey®	  Imager	  (Li-­‐Cor	  Biosciences	  GmbH). 
 
6.4 Cell Culture Methods 
6.4.1 Cultivation 
An aliquot of frozen U2OS cells, received from Ingrid Kassner (IVBMB, Zürich), 
was thawed at 37°C for 5 to 10 minutes. The cells were transferred to a 15 ml falcon tube and 
centrifuged at 251 rcf for 5 minutes. Afterwards, the cells were resuspended in fresh medium 
and seeded in a six well dish (TTP). U2OS cells were cultured in DMEM containing stable 
glutamine and supplemented with 10% fetal calf serum and 1% penicillin/streptomycin. Cells 
were grown in an incubator at 37°C, 5% CO2. Before reaching confluency, cells were split. 
For splitting, plates containing cells were washed with PBS and then 1,5 ml trypsin-EDTA 
was added to a 10 cm plate. After 2 minutes incubation in the incubator, cells were collected 
from the plate with 3 ml DMEM and transferred to a 15 ml falcon tube. Cells were counted 
with the Casy Counter (Roche innovatis AG) and approximately 8x105 cells were seeded 
again on a 10 cm plate. 
 
6.4.2 Transient Cell Transfection 
U2OS cells in six well dishes were grown until they reached a confluence of 80% and 
then transfected with transit LT1 (Mirus). A transfection solution was prepared (2 ml DMEM 
medium, 100 µl Opti-MEM (Invitrogen), 1,5 µg DNA and 4,5 µl transit LT1) and used 
according to the manufacturer’s protocol. 
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6.4.3 Life Cell Imaging 
Cells were analyzed by fluorescence microscopy (Leica, DMI6000 B) 3 days after 
transfection. U2OS cells, grown in six well dishes, were directly taken from the incubator to 
the microscope for the analysis, without removing the DMEM medium. After a short general 
inspection to evaluate the transfection rate, single clusters of cells were analyzed under 
fluorescent light (filter I3, 488 nm excitation laser light) or in phase contrast mode. A merged 
picture (fluorescence and phase contrast) was obtained by overlaying the single pictures.
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7 Results 
7.1 Published Results 
7.1.1 Crosstalk between Set7/9-dependent Methylation and ARTD1-mediated ADP-
ribosylation of Histone H1.4 
Authors: Ingrid Kassner, Marc Barandun, Monika Fey, Michael O. Hottiger 
Journal: Epigenetics Chromatin. 2013 Jan 5;6(1):1. 
Contribution: Planning, performing (includes cloning and protein expression) and evaluating 
the experiments described in Figure 3A, F3C, F3D and supplementary Figure S2B, S2C and 
S2D 
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RESEARCH Open Access
Crosstalk between SET7/9-dependent methylation
and ARTD1-mediated ADP-ribosylation of histone
H1.4
Ingrid Kassner1,2, Marc Barandun1, Monika Fey1, Florian Rosenthal1,2 and Michael O Hottiger1*
Abstract
Background: Different histone post-translational modifications (PTMs) fine-tune and integrate different cellular
signaling pathways at the chromatin level. ADP-ribose modification of histones by cellular ADP-ribosyltransferases
such as ARTD1 (PARP1) is one of the many elements of the histone code. All 5 histone proteins were described to
be ADP-ribosylated in vitro and in vivo. However, the crosstalk between ADP-ribosylation and other modifications is
little understood.
Results: In experiments with isolated histones, it was found that ADP-ribosylation of H3 by ARTD1 prevents
H3 methylation by SET7/9. However, poly(ADP-ribosyl)ation (PARylation) of histone H3 surprisingly allowed
subsequent methylation of H1 by SET7/9. Histone H1 was thus identified as a new target for SET7/9. The SET7/9
methylation sites in H1.4 were pinpointed to the last lysine residues of the six KAK motifs in the C-terminal domain
(K121, K129, K159, K171,
K177 and K192). Interestingly, H1 and the known SET7/9 target protein H3 competed with each other for
SET7/9-dependent methylation.
Conclusions: The results presented here identify H1.4 as a novel SET7/9 target protein, and document an intricate
crosstalk between H3 and H1 methylation and PARylation, thus implying substrate competition as a regulatory
mechanism. Thereby, these results underline the role of ADP-ribosylation as an element of the histone code.
Keywords: PARP-1, SET7/9, Lysine methylation, Poly-ADP-ribosylation, Post-translational modification
Background
Histones are nuclear proteins that package and order the
DNA into nucleosomes [1]. Five major families of his-
tones exist: H1 (H5), H2A, H2B, H3, and H4. Two cop-
ies of the core histones H2A, H2B, H3 and H4 form the
octameric nucleosome core particles [2]. Unlike the
other histones, only one copy of the linker histone H1 is
present and stabilizes the DNA, which is wrapped
around the core nucleosome [3]. Linker histones bind to
both the nucleosome and the linker DNA region (ap-
proximately 20 to 80 nucleotides in length) between
nucleosomes. The interaction of H1 with the nucleo-
some and additional DNA stretches at the entry/exit of
the nucleosome forms the chromatosome and leads to
higher order chromatin structure [4]. Many experiments
addressing H1 function have been performed with puri-
fied, processed chromatin under low-salt conditions, but
the in vivo role of H1 is less clear. Cellular studies have
shown that overexpression of H1 can cause aberrant nu-
clear morphology and chromatin structure and, depend-
ing on the gene, H1 can serve as either a positive or a
negative regulator of transcription [5]. Similar to the
core histones, H1 is composed of three domains [6]. The
N-terminus is a short, flexible segment rich in basic
amino acids, the central domain exhibits a globular
structure composed of a winged helix motif [6] and
the C-terminus is predominantly composed of lysine,
alanine and proline residues and is the main determin-
ant for H1 binding to chromatin [7]. Among the five
histone families of the chromatosome, the linker his-
tone H1 is the least conserved. In the human genome,
11 genes encoding H1 variants have been identified and
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are transcribed either ubiquitously or in a cell type-
specific manner [4,8]. The study described here focuses
on histone H1.4, a histone variant that is expressed
in somatic cells during S phase. Together with H1.2
it is the predominant histone variant in most cell
types. Similar to the core histones, linker histones are
subject to extensive post-translational modifications
(PTMs), including phosphorylation, methylation and
acetylation [9].
SET7/9 (also SET7, SET9, SETD7 or KMT7) is a
mono-methyltransferase for the lysine residue at pos-
ition 4 of histone H3 (H3K4) [10,11] that was linked to
transcriptional activation. It methylates the consensus
motif [K>R][S>KYARTPN][Kme] and prefers lysine resi-
dues within positively charged regions [12]. However,
SET7/9 exhibits only weak lysine methyltransferase ac-
tivity towards H3 in nucleosomes in vitro, suggesting
that additional factors may affect SET7/9-dependent
H3K4 methylation in vivo, or that histone proteins are
not the main substrates of SET7/9. Lysine methylation
can be reversed by demethylases of the lysine-specific
demethylase (LSD) family or the Jumonji-C domain fam-
ily of proteins [13,14].
In contrast to the canonical PTMs of the histone code,
adenosine diphosphate (ADP)-ribosylation is much less
studied. ADP-ribosylation comprises the transfer of the
ADP-ribose moiety from the co-substrate nicotinamide ad-
enine dinucleotide (NAD+) onto specific amino acid side
chains of acceptor proteins or to pre-existing protein-linked
ADP-ribose units by ADP-ribosyltransferases (ARTs).
Mammalian ARTs can be divided into two groups accord-
ing to their similarity to the bacterial diphtheria and cholera
toxins - the ARTDs (also known as poly(ADP-ribose) poly-
merases (PARPs)) and ARTCs, respectively [15]. ARTD1
(PARP1) is the best-studied member of the ARTD family
and represents a highly abundant (on average 1 × 106
molecules per cell), chromatin-associated enzyme that is
responsible for most (about 90%) of the cellular PAR
generation [16,17]. It is implicated in many cellular
processes such as the genotoxic stress response, cell cycle
regulation, gene expression, differentiation and aging
[18,19]. The major modification target of ARTD1 is ARTD1
itself, but it also modifies other nuclear proteins including
all five histone proteins in vitro and in vivo [20]. In native
chromatin, histone H1 is the main ADP-ribose acceptor,
but depending on the chromatin composition and the
accessibility of different histones, the ADP-ribosylation
pattern of histones varies [21,22]. Mass spectrometry and
electron-transfer dissociation (ETD) identified for the first
time K13 of histone H2A, K30 of H2B, K27 and K37 of H3
as well as K16 of H4 as ADP-ribose acceptor sites
(catalyzed by ARTD1) [23].
Crosstalk between different PTMs occurs directly by
competition for acceptor sites or indirectly by changes
in the accessibility of chromatin for modifying enzymes.
The observation that specific lysine residues serve as
ADP-ribose acceptors is important because the same
amino acid residues are potential acetylation and methy-
lation sites [24]. It is therefore likely that competition for
acceptor sites between different histone PTMs such as
ADP-ribosylation, acetylation, methylation and phos-
phorylation causes crosstalk [20]. This has been demon-
strated by the finding that acetylation of lysine residue
K16 of histone H4 inhibits ADP-ribosylation in vitro [23],
which suggests that different crosstalk likely exists
in vivo as well. Similarly, H1.4 K26 dimethylation and
AuroraB-mediated phosphorylation of S27 have been
reported to interfere with each other [25]. Whether
or not other modifications of the histone code such
as methylation or phosphorylation also crosstalk with
ADP-ribosylation has not been studied before.
Here, we define the linker histone H1.4 as a novel
target of SET7/9-dependent methylation, identify lysines
K121, K129, K159, K171, K177 and K192 as methyl
acceptor sites and describe crosstalk between H1.4
methylation and ADP-ribosylation as well as competi-
tion with histone H3 methylation.
Results and discussion
PARylation inhibits SET7/9-dependent methylation of
histone H3
ADP-ribosylation is a PTM of a wide variety of target
proteins, including histones [20,23,26]. However, since
histone tails are subject to many types of PTMs, cross-
talk between different modifications likely exists.
Therefore, it was investigated whether histone PARylation
by ARTD1 affects consecutive SET7/9-dependent H3
methylation. A histone mix was PARylated for different
time periods and then subjected to methylation assays with
SET7/9 and radio-labelled S-adenosyl-L-(methyl-14C)
methionine (14C-SAM) as methyl donor. ARTD1 and
histones were both strongly PARylated and the level
of modification correlated with the reaction times
(see Additional file 1). In the absence of PARylation,
mainly core histones, which comprise H3, were methylated
(time-point 0) (Figure 1A). However, after 1 minute of
PARylation of the histones by ARTD1, the methylation of
core histones was already strongly reduced.
As a control for these results, recombinant H3 was
incubated with ARTD1, NAD+ and with or without
DNA (to stimulate ARTD1) and 3-AB (to inhibit
ARTD1). H3 was methylated by SET7/9 if ARTD1 was
inactive or inhibited (Figure 1B, lanes 1 and 4), but pre-
vented in the samples containing activated ARTD1
(Figure 1B, lanes 2 and 3). PARylation of SET7/9 was
not the cause for this effect, because the methyltransfer-
ase was only added after the PARylation reaction and
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addition or omission of 3-AB did not affect the result
(Figure 1B, lanes 2 and 3).
PARylation of histone H3 allows methylation of H1 by
SET7/9
Interestingly, ADP-ribosylation of H3 for 1 or 2 minutes
and subsequent inhibition of its methylation resulted in
an unexpected and strong H1 methylation (Figure 1A).
In order to confirm H1 methylation by SET7/9, experi-
ments with purified H1 were performed. As before, H1
was incubated with ARTD1, NAD+ and with or without
DNA and 3-AB. Similar to H3, histone H1 was methy-
lated by SET7/9 in the absence of active ARTD1, but H1
methylation was completely inhibited by PARylation
(Figure 1C). These results suggested that in addition to
H3, histone H1 is a new methylation target of SET7/9
and that prior PARylation of H1 and H3 prevents con-
secutive methylation by SET7/9.
Histones H1 and H3 compete for SET7/9-dependent
methylation
The results presented so far suggested that H1 and H3
are both methylated by SET7/9, but only in the absence
of PARylation. ARTD1-dependent PARylation might
thus modulate which histone protein is methylated. To
test this hypothesis, in vitro competition experiments
with or without PARylation of H1 and H3 were per-
formed. H1 and H3 were strongly methylated by SET7/9
if present alone (Figure 2A, lanes 1 and 5). However, H1
and H3 competed with each other when present in the
same reaction and thus lead to a reduced methylation
signal (lanes 2 to 4). Prior PARylation of histone H3
completely abolished its competing activity for SET7/9-
dependent H1 methylation (lanes 6 to 7). To further
study and confirm this finding, a PARylation time course
experiment with histone H1 or histone mix prior to
SET7/9 methylation was performed. Set7/9-dependent
methylation of H1 was abolished after 15 minutes of
PARylation by ARTD1 (Figure 2B). In contrast, H3
methylation in a histone mix was already inhibited after
5 minutes of ARTD1 treatment, which lead to consecu-
tive H1 methylation by Set7/9 (Figure 2C). In both cases,
addition of the histones after the PARylation reaction
did not influence consecutive Set7/9-dependent methy-
lation (that is, H1 was methylated only if H3 was not
present).
These results suggested that, in comparison to H1, H3
is preferentially modified by both, SET7/9 and ARTD1.
In the short window when H1 methylation is inhibited
due to PARylation but H3 is not yet fully ADP-ribosylated,
SET7/9 dependent methylation of H3 is detectable. This
example thus illustrates how different affinities for
modifying enzymes can induce a switch of target pro-
teins. These results suggest that differential PARylation
of histone proteins by ARTD1 can indirectly influence
histone methylation and thus the histone code by deter-
mining which target proteins are modified. In addition
to crosstalk between PARylation and methylation,
SET7/9 function is thus also subject to crosstalk
between different substrates (for example, H3 and H1).
Figure 1 PARylation inhibits SET7/9-dependent methylation of histone H3 and H1. (A) ARTD1 was auto-modified for the indicated times
and then inhibited by addition of PJ-34. A histone mix was added to the reaction either before or after the inhibition of ARTD1. Methylation was
started after PJ-34 addition by adding SET7/9 and 14C-SAM. Proteins were separated by SDS-PAGE, stained with Coomassie blue (CB, lower blot)
and methylation was analyzed by autoradiography (14C, upper blot). The asterisk marks the shift of automodified ARTD1. (B) H3 was incubated
with ARTD1 and 160 μM NAD+. Activating DNA and PARP inhibitor 3-AB were present during the reaction as indicated. Methylation was then
started by addition of SET7/9 and 14C-SAM ± 3-AB was added directly before addition of SET7/9 after the PAR reaction. (C) Influence of ARTD1 on
H1 methylation as in (B). The approximate molecular weight is indicated on the left of each gel/blot.
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The C-terminus of linker histone H1.4 is methylated by
SET7/9
In order to characterize the new SET7/9 methylation
target H1, different fragments of H1.4 were created and
their methylation was analyzed. Interestingly, full-length
histone H1.4 was not methylated in the presence of plas-
mid DNA and neither was an H1.4 mutant lacking the
C-terminus (ΔCT) (Figure 3A). These results suggested
that H1.4 is methylated at the C-terminal domain
(CTD), which has been reported to bind to DNA, and
that SET7/9 likely methylates soluble H1.4 that is
not part of the chromatin structure. In order to locate
the methylation site in histone H1.4, recombinant,
C-terminally truncated, HIS-tagged H1.4 fragments as
well as short fragments of the CTD were analyzed
(Figure 3B). Full length H1.4 (aa 1 to 219) was strongly
methylated, while partial truncation of the CTD (1 to
189 or 1 to 156) caused reduced SET7/9-dependent
methylation (Figure 3C). To further pinpoint the methy-
lation sites in the H1.4 CTD, three H1.4 fragments
covering the whole CTD were expressed as glutathione-
S-transferase (GST)-fusion proteins (aa 114 to 144, 145
to 189, 190 to 219, Figure 3B) and used in methylation
assays. All three fragments were methylated by SET7/9,
albeit to different degrees (Figure 3D). Fragment 190 to
219 showed the strongest methylation, while the frag-
ment from amino acids 114 to 144 was only weakly
methylated, suggesting that multiple SET7/9-dependent
methylation sites are present in the CTD of H1.4. These
results demonstrated that the linker histone H1.4 is
methylated by SET7/9 in vitro.
Linker histone H1.4 is methylated at six lysine
residues of the C-terminal domain
In order to define all SET7/9-dependent methylation
sites in the CTD of the H1.4, the C-terminal fragments
(114 to 144, 145 to 189, 190 to 219) were further muta-
genized. Since the strongest methylation was seen for
fragments 145 to 189 and 190 to 219, these peptides
were subjected to a cluster mutation approach. Seven ly-
sine clusters that comprised all potential methylation
sites were defined and in each of these clusters all lysine
Figure 2 Histones H1 and H3 compete for SET7/9-dependent
methylation. (A) H3 and H1 compete for methylation by SET7/9. H1
was methylated in presence of the indicated molar ratios of H3. In
lanes 6 and 7, H3 was incubated with ARTD1 and NAD+ in the
presence or absence of 3-AB before addition of H1 and the
methylation reaction. (B) ARTD1 was auto-modified for the indicated
times and then inhibited by addition of PJ-34. H1 was added to the
reaction either before or after the PARylation. Methylation was
started after addition of PJ-34 by adding SET7/9 and 14C-SAM. (C) As
for (B), but a histone mix was used.
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Figure 3 Linker histones are methylated by SET7/9. (A) HIS-tagged H1.4 FL and a deletion mutant without the CTD (ΔCTD) were in vitro
methylated by SET7/9 in the presence or absence of plasmid DNA. (B) Schematic depiction of H1.4 wild-type (WT) protein and constructs. NTD,
N-terminal domain; GD, globular domain; CTD, C-terminal domain; ΔCT, H1.4 construct completely lacking the C-terminus. (C) Recombinant HIS-
tagged H1.4 full-length (FL) and deletion mutants were methylated in vitro by SET7/9. (D) H1.4 C-terminal fragments were expressed as GST
fusion proteins and methylated in vitro by SET7/9. Methylation was analyzed by autoradiography.
Figure 4 Full-length H1.4 is methylated at six lysine residues by SET7/9. (A) Mutation of the four lysine residues K159, K171, K177 and K192
(K4R) in wild-type (WT) H1.4 reduces SET7/9-dependent methylation. The additional mutation of K121 and K129 (K6R) abolishes methylation of
full-length H1.4 by SET7/9. (B) H1.4 is efficiently PARylated after methylation by SET7/9. H1.4 was first incubated with S-adenosyl-L-(methyl-14C)
methionine (14C-SAM) and glutathione-S-transferase (GST) or SET7/9 and then incubated with ADP-ribosyltransferase-D1 (ARTD1) in the presence
or absence of cold nicotinamide adenine dinucleotide (NAD)+. (C) H1.4 K6R is still modified by ARTD1. H1.4 WT and K6R were incubated with
ARTD1 in the presence of 250 μM NAD+. PARylation was analyzed by Western blotting.
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residues were mutated to arginines (Additional file 2,
Figure S2A). Mutation of cluster 4 and cluster 6 did not
interfere with the methylation of the H1.4 fragments, in-
dicating that the lysine residues located in these two
clusters are not methylated by SET7/9 (Additional file 2:
Figure S2B). The remaining cluster mutants 1, 2, 3, 5
and 7 were less methylated than the wild-type (WT)
proteins (Additional file 2: Figure S2B). Computational
analysis of these clusters as well as the fragment 114 to
144 identified six putative SET7/9 target sites matching
the (KR)(STA)K consensus motif for SET7/9-dependent
methylation [27]. These lysines at position 121, 129, 159,
171, 177 and 192 represent the last residues of the
six KAK motifs in the CTD of H1.4 (Additional file 2,
Figure S2A).
The corresponding lysine residues were then mutated
individually and in combination. Only the mutation of
all three lysines (K159, K171, K177) of the fragment 145
to 189 completely abolished the methylation of this pep-
tide (Additional file 2, Figure S2C). Similarly, the K192R
mutation abrogated the SET7/9-dependent methylation
of fragment 190 to 219 (Additional file 2, Figure S2D).
Interestingly, the combination of all four mutations
(K159R, K171R, K177R and K192R) did not completely
prevent the methylation of full-length H1.4 (Figure 4A).
The additional mutation of K121 and K129 of the
fragment 114 to 144 to arginines reduced the SET7/9-
dependent methylation of full-length H1.4 most signifi-
cantly, although a faint signal was sometimes observed
even for this peptide (Figure 4A).
In summary, the mapping of the methylation sites in
the H1.4 CTD thus identified the KAK motif and the six
lysines K121, K129, K159, K171, K177 and K192 as the
targets for SET7/9-dependent methylation of this linker
histone variant.
Histones H1.4 and H3 methylation does not affect
PARylation
The initial observation revealing H1 methylation by
SET7/9 indicated crosstalk between PARylation and
methylation as well as competition between H3 and
H1.4. In order to elucidate the nature of this crosstalk,
the influence of methylation on PARylation was studied
and additional competition experiments with H1.4 and
H3 were performed.
Prior methylation by SET7/9 did not prevent consecu-
tive H1.4 PARylation, as observed by the shift of methy-
lated H1 (Figure 4B). Similarly, the non-methylated H1.4
K6R mutant and WT H1.4 were modified by ARTD1
comparably (Figure 4C). These results clearly indicated
that PARylation and SET7/9-dependent methylation of
H3 and H1.4 do not crosstalk due to the same modifica-
tion sites, even though prior PARylation does prevent
methylation (Figures 2B, 2C). It is therefore likely that
PARylation inhibits SET7/9 interaction with PARylated
H3 or H1.4 and thereby prevents methylation.
Conclusions
This study describes the linker histone H1.4 as a new
target for the H3K4 mono-methyltransferase SET7/9.
Full-length histone H1.4 was methylated by SET7/9 at
the lysine residues K121, K129, K159, K171, K177 and
K192 of the KAK motifs of the CTD, which suggests a
strong preference of SET7/9 for this recognition se-
quence. However, some of the KAK motifs seemed pre-
ferentially methylated, which may indicate a sequential
modification or hint at differences in the accessibility of
the different methylation sites.
The addition of plasmid DNA abolished SET7/9-
dependent methylation of target proteins, indicating that
incorporation into the nucleosome structure and DNA
binding prevents methylation. This could be explained
by DNA-induced conformational changes of the H1
CTD and by charge neutralization through DNA, as
SET7/9 is known to prefer lysine residues in a positively
charged context. Likewise, methylation may directly in-
fluence the binding of H1 to DNA and its function in
chromatin compaction, especially as the six lysine resi-
dues targeted by SET7/9 all reside in the CTD of H1.4,
which is important for chromatin binding [28]. These
findings may indicate that SET7/9-dependent H1 methy-
lation appears when H1 is not chromatin bound and
possibly influences its turnover and exchange, which
extends the scope of the histone code to the extra-
chromatin realm.
Covalent histone modifications can alter chromatin
structure and thereby define transcriptionally active or
inactive chromatin states [29]. Compared with core his-
tones, little is known about the modifications and the
corresponding modifiers of the linker histones. One pos-
sible function of H1 methylation by SET7/9 might be
the stimulation or repression of other post-translational
modifications. Crosstalk between K26 dimethylation and
AuroraB-mediated phosphorylation of S27 has been
reported previously [25]. In addition, the H1.4 CTD is the
target of acetylation, ADP-ribosylation and phosphorylation
[30,31]. Interestingly, the four last KAK motifs, which
displayed the strongest methylation in vitro, are located in
close proximity to well known CDK phosphorylation sites
(Figure 5A), which suggests a potential for significant
crosstalk between acetylation, methylation and phosphoryl-
ation. Two of the sites in this region, S172 and S187, are
not exclusively phosphorylated during mitosis and their
phosphorylation in interphase correlated with transcription
and chromatin relaxation [32]. Crosstalk between dif-
ferent histone modifications of H1.4 thus can fulfill im-
portant cellular functions. However, in most cases the
modifying enzymes are currently not known and thus
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the biological and cellular functions of these modifica-
tions have not been elucidated in detail yet.
ARTD1 and histone ADP-ribosylation were previously
suggested as components of the histone code [20,26]. The
results described here provide a further line of evidence
for this hypothesis. We show that ARTD1-dependent
PARylation of histones influences their subsequent methy-
lation by SET7/9. Compared to phosphorylation, which
strongly reduces methylation if in proximity of SET7/9
target lysine residues [12], PARylation is a much more
bulky modification with more negative charges and
therefore also inhibited histone methylation by SET7/9.
Based on the experiments shown here, SET7/9 methy-
lates both H1 and H3, but prefers H3 if both substrates
are present. Strikingly, PARylation did not merely in-
hibit SET7/9-dependent methylation of histones, but
shifted its target from H3 to H1 (Figure 5B). These
observations could be explained by sequential PARyla-
tion events, where ARTD1 modifies H3 before H1.
PARylation of H3 would then inhibit its subsequent
methylation by SET7/9 and its competition as a SET7/9
target with H1.
This ARTD1-dependent regulation of the substrate
specificity of a histone modifying enzyme may be an ex-
citing mechanism to explain how ARTD1 influences
chromatin-associated processes such as transcription. It
is also important to note that progressive PARylation of
histones also inhibited the methylation of H1, docu-
menting that different outcomes for SET7/9-dependent
histone methylation can occur depending on the extent
of ARTD1 activity.
The complexity of ARTD1-dependent histone modifi-
cations is increased by the facts that (1) ARTD1 can
modify all core histones and the linker histones [23], and
(2) the size and quality (for example, branching or
length) of the polymers may differ under varying condi-
tions and depending on the substrate histone. Therefore,
future studies should not merely focus on the influence
of ARTD1 and PARylation on other histone modifica-
tions but also on how ARTD1-dependent histone modi-
fication itself is regulated. In this regard, it will also be
interesting to study specific ADP-ribose modifications
and their effect on SET7/9 methylation. Although we
have identified ADP-ribose acceptor sites in histones
(for example, K37 of H3) it is not yet possible to chem-
ically synthesize peptides with specific ADP-ribose mod-
ifications required for these studies. Furthermore,
antibodies specific for a particular ADP-ribose modifica-
tion have not been developed. In the future, such tools
will allow study of the effect of SET7/9-dependent
Figure 5 Crosstalk between adenosine diphosphate-ribosyltransferase (ARTD)-1 and SET7/9-dependent modification of linker and
core histones. (A) Summary of known post-translational modification sites of H1.4. The grey box marks the central globular domain. The
six newly identified KAK motifs that are methylated by SET7/9 are highlighted in red. Blue: PARylation (PAR), red: phosphorylation (P),
green: methylation (me, number indicates methylation state). (B) Model of the sequential adenosine diphosphate (ADP)-ribosylation and
methylation reactions on histone H3 and H1 by ARTD1 and SET7/9.
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methylation on ARTD1 activity and modification sites in
much more detail.
Methods
Plasmids and protein expression
pGEX-SET7/9 (52 to 366) and pET28b-H1.4 (fl) bacterial
expression vectors were kind gifts from D Reinberg and R
Schneider, respectively. H1.4 full-length and deletions
mutants were subcloned into pET-28a to add the N-
terminal HIS-tag. C-terminal H1.4 fragments were cloned
into pGEX6P1. All point mutations were inserted by site-
directed mutagenesis. Cluster mutants were created by
overlapping PCR with the corresponding primers.
The baculovirus expression vector BacPak8 (Clontech,
Mountain View, CA, USA) was used for the expression
of recombinant ARTD1 in Sf21 insect cells, as described
previously [33]. GST- and HIS-tagged histone proteins
were expressed in E.coli. All recombinant proteins were
purified by a one-step affinity chromatography using
ProBond resin (Invitrogen, Paisley, UK) for HIS-tagged
and glutathione sepharose (GE Healthcare, Uppsala,
Sweden) for GST-tagged proteins, according to the man-
ufacturer‘s recommendations. HIS-H1.4(fl) proteins were
purified as described elsewhere [34].
Reagents
Lyophilized histones or H1 mix from calf thymus were
purchased from Roche (Rotkreuz, Zug, Switzerland) and
resolubilized in water. The 3-AB (Sigma-Aldrich, St. Louis,
MO, USA) was freshly prepared in water.
In vitro methylation assays
If not stated otherwise, approximately 1 μg histone
proteins were incubated with 1 μg bacterially purified
GST-SET7/9 in the presence of 0.03 μCi 14C-SAM
(PerkinElmer, Boston, MA, USA) in methylation buffer
(50 mM Tris–HCl pH8.0, 50 mM NaCl, 10% glycerol, 1
mM PMSF, 1 mM DTT) for 10 to 60 minutes at 30°C in
a 25 μl reaction. For DNA inhibition assays, histones
were preincubated with or without 0.5 μg plasmid DNA
(pcDNA) and then methylated for 15 minutes. Reactions
were stopped by addition of 10× SDS-loading buffer,
boiled and separated by SDS-PAGE. Gels were stained
with CB, incubated in 1 M sodium salicylate for 20
minutes, dried, and exposed on x-ray film at −80°C.
Sequential ADP-ribosylation and methylation assays
Sequential modification assays were performed in PAR
buffer (50 mM Tris–HCl, 50 mM NaCl, 4 mM MgCl2,
250 μM DTT, 1 mg/ml pepstatin, 1 mg/ml bestatin, 1
mg/ml leupeptin).
We incubated 10 pmol ARTD1, with or without 2.5 μg
histone mix or 1 μg individual histones, in the presence
or absence of 5 pmol activating DNA and 160 μM NAD+
(Sigma-Aldrich, St. Louis, MO, USA) for 15 minutes at
30°C; 8 mM 3-AB or 0.2 mM PJ-34 were added to inhibit
ARTD1 activity either before the ADP-ribosylation or
afterwards, where indicated. The methylation was then
started by addition of 1 μg SET7/9 and 0.03 μCi 14C-SAM
and allowed to proceed for 1 h at 30°C. Autoradiography
was performed as described above. The activating DNA
used in all assays was an annealed double-stranded
oligomer (5’-GGAATTCC-3’).
Additional files
Additional file 1: Figure S1. Time-dependent PARylation of adenosine
diphosphate-ribosyltransferase (ARTD)-1 and histones. ARTD1 and a
histone mix were modified for the indicated times. Proteins were
separated by SDS-PAGE, stained with Coomassie blue (CB, upper blot)
and adenosine diphosphate (ADP)-ribosylation was analyzed by
autoradiography (32P, lower blots showing a long and short exposure).
The mobility shift of poly-ADP-ribosylated ARTD1 is marked in the SDS-
PAGE gel.
Additional file 2: Figure S2. H1.4 C-terminal domain (CTD) is
methylated at KAK* motifs. (A) Amino acid sequences of C-terminal H1.4
fragments. Boxes represent the lysine clusters which were mutated to
arginines in (B). Grey boxes mark the clusters that markedly influence
methylation. KAK motifs are highlighted in dark grey and the methylated
lysines are bold. (B) Cluster mutant approach to identify methylation sites
in H1.4 CTD, which contains 43 lysine residues as potential target sites.
Clusters were mutated one by one in the corresponding C-terminal
fragment and methylation efficiency by SET7/9 was tested in vitro. (C)
Methylation of C-terminal fragments by SET7/9 was tested in vitro after
mutation of single lysine residues in KAK* motifs. (D) Methylation of H1.4
(145–189) double and triple mutants by SET7/9.
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LEGENDS OF SUPPLEMENTARY FIGURES 
 
Figure S1. Time-dependent PARylation of ARTD1 and histones. ARTD1 and a histone 
mix were modified for the indicated times. Proteins were separated by SDS-PAGE, stained 
with Coomassie blue (CB, upper blot) and ADP-ribosylation was analyzed by 
autoradiography (32P, lower blots showing a long and short exposure). The mobility shift of 
poly-ADP-ribosylated ARTD1 is marked in the SDS-PAGE gel.  
 
Figure S2. H1.4 CTD is methylated at KAK* motifs. (A) Amino acid sequences of C-
terminal H1.4 fragments. Boxes represent the lysine clusters which were mutated to arginines 
in (B). Grey boxes mark the clusters that markedly influence methylation. KAK* motifs are 
highlighted in dark grey and the methylated lysines are bold. (B) Cluster mutant approach to 
identify methylation sites in H1.4 CTD which contains 43 lysine residues as potential target 
sites. Clusters were mutated one by one in the corresponding C-terminal fragment and 
methylation efficiency by SET7/9 was tested in vitro. (C) Methylation of C-terminal 
fragments by SET7/9 was tested in vitro after mutation of single lysine residues in KAK* 
motifs. (D) Methylation of H1.4 (145-189) double and triple mutants by SET7/9. 
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Supplementary Figure 1 
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Supplementary Figure 2 
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7.2 Unpublished Results 
7.2.1 DNA inhibits Methylation of full-length or the Histone H1.4 Deletion Mutants 
To investigate whether the addition of DNA alters the methylation of H1.4 by SET7/9, the 
same constructs as described in section 6.1 (H1.4 full-length (amino acids 1-210) C-terminal 
mutant 1 (1-189), the C-terminal mutant 2 (1-156) and the C-terminal mutant 3 (1-113)) were 
incubated with SET7/9 and 30nCi SAM in the presence or absence of 0.5 µg DNA (Fig 14A 
and B).  
 
A 
 
B 
 
Figure 14: Structural features of H1.4. A: Histone H1.4 is comprised of an N-terminal, a globular and a C-
terminal domain. We have created deletion mutants lacking parts of their C-terminus. B: Amino acid sequence 
of H1.4 colored accordingly to the domain they represent (N-terminal tail: grey, globular domain: black, C-
terminal domain: brownish) with the potential methylated lysine residues in red.  
 
After the incubation, the reaction was stopped and the proteins were separated by 
SDS-PAGE. The gel was stained with Coomassie, vacuum dried and then exposed to a film 
(Fig. 15). 
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Figure 15: SET7/9-induced methylation of full-length and different H1.4 deletion mutants in the presence or 
absence of pcDNA. Autoradiography of a 15% SDS-PAGE after methylation and separation of the different 
proteins (3 days exposure; upper panel). The lower panel shows the Coomassie stained gel to visualize the 
protein levels of SET7/9, full-length H1.4 (FL) and different H1.4 deletion mutant (1, 2 or 3). 
 
The presence of DNA inhibited the methylation of full-length and H1.4 deletion 
mutants 1 and 2. The deletion mutant 3 was not methylated and thus not inhibited. Even after 
long exposure of the x-ray film, no radioactive signal could be detected, suggesting that the 
methylation of linker histone H1.4 and of its C-terminal fragments is completely inhibited by 
DNA under these conditions.  
 
7.2.2 Different H1.2 C-terminal Domain Cluster Mutants are methylated by SET7/9 to 
the same Extent 
Before focusing on H1.4, a cluster mutation approach for H1.2 was performed to 
further investigate potential modification sites. Therefore, several lysine residues were 
deleted together in clusters. Hereby, it was helpful that cluster mutants in the entire C-
terminal tail were already available from Robert Schneider (MPI Freiburg, Germany), who 
used these mutants to characterize the methylation site of other methyltransferases such as 
G9a/KMT1C and Glp1/KMT1D in H1.2 177. We therefore decided to analyze the SET7/9-
induced methylation pattern of these H1.2 cluster mutants with the expectation to identify 
conserved lysine residue(s) not only present in H1.2 but also in H1.4. 
The C-terminal domain of H1.2 contained 10 clusters (Cl1-Cl10) that comprised all 
40 potential lysine acceptors for the methylation by SET7/9. Different constructs containing 
either single or multiple mutations were cloned into the pET expression vector replacing the 
original amino acid sequence of each cluster with a lysine free amino acid sequence. The 10 
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C-terminal polypeptides were expressed in E. coli and purified by using perchloric acid to 
dissolve the inclusion bodies, which contained the His-tagged proteins (see also Materials 
and Methods) (Fig. 16). 
 
 
Figure 16: Amino acid sequence of the histone H1.2 cluster mutants. 
 
To analyze whether one of the cluster mutants is no longer methylated, the purified 
polypeptides were separately incubated for 1 hour at 30°C with SET7/9 and 30 nCi SAM. 
After terminating the reaction, the proteins were analyzed by SDS-PAGE and subsequent 
exposure of the gel to an X-ray film (Fig. 17A and B). 
 
A:  
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 B:  
 
Figure 17: A: SET7/9-induced methylation of the H1.2 cluster mutants. Autoradiography of a 15% SDS-PAGE 
after methylation and separation of the different proteins (3 days of exposure; upper panel). H1 mix from Roche 
was included as a control (wt). The lower panel shows the Coomassie stained gel to visualize the protein levels 
of SET7/9 and the H1.2 cluster mutants (Cl1-Cl1+3+5). B: SET7/9-induced methylation of H1.2 cluster 
mutants. Autoradiography of a 15% SDS-PAGE after methylation and separation of the different proteins (4 
days exposure; upper panel). The C-terminal domain of H1.2 with an additional linker was included as positive 
control (wt). The lower panel shows the Coomassie stained gel to visualize the protein levels of SET7/9 and the 
cluster mutants of H1.2 (Cl7-Cl10). 
 
As a positive methylation control, a commercial histone H1 from Roche or the wt C-
terminus was used. As observed for H1.4, the C-terminus of H1.2 was also methylated by 
SET7/9. The tested clusters in Figure 17A showed differential methylation. Unfortunately, 
none of the tested cluster mutants showed a complete loss of the radioactive signal. The Cl2 
mutant and combinations of multiple cluster mutants (e.g., Cl1 and Cl3) seemed less 
methylated than Cl3 alone, indicating that there are possibly several methylation sites, which 
are located in different parts of the C-terminal tail of H1.2. On the other hand, the strong 
reduction observed for mutant Cl1+Cl3 could not be explained by an additive effect of the 
single clusters and furthermore indicates that this approach was subjected to a certain 
fluctuation. This was supported by the fact, that constructs with an additional cluster (e.g., 
Cl1, Cl3 and Cl5) were stronger methylated than the construct with only Cl1 and Cl3. 
None of the clusters Cl7 to Cl10 showed any reduction in methylation when 
compared to the wt control, indicating that either this part of the C-terminus is not methylated 
or that mutating only one cluster is not enough to observe reduced methylation.  
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7.2.3 Changing the pH from 8 to 7.2 or 9 does not alter Methylation of H1.2 by SET7/9 
As there were no strong differences in methylation of the H1.2 cluster mutants by 
SET7/9 under the standard conditions, the reaction was repeated at different pHs in order to 
increase the specificity of the methylation. The pH for the reaction was either decreased from 
pH 8 to pH 7.2 (Fig. 18) or increased to pH 9 (Fig. 19).  
 
 
Figure 18: SET7/9-induced methylation of H1.2 cluster mutants at pH 7.2. Autoradiography of a 15% SDS-
PAGE after methylation and separation of the different proteins (3 days exposure; upper panel). Coomassie 
stained gel to visualize the protein levels of SET7/9, the cluster mutants of H1.2 (Cl1-Cl1+3+5 and Cl7-10) and 
the C-terminal tail as control (wt) is shown in the lower panel.  
 
 
Figure 19: SET7/9-induced methylation of H1.2 cluster mutants at pH 9. Autoradiography of a 15% SDS-PAGE 
after methylation and separation of the different proteins (overnight exposure; upper panel). Coomassie stained 
gel to visualize the protein levels of SET7/9, the cluster mutants of H1.2 (Cl1-Cl1+3+5 and Cl7-10) and the wt 
C-terminal tail (wt) is shown in the lower panel.  
  
Moreover, the incubation time with SET7/9 and 30nCi SAM was reduced from 1 hour to 
only 15 minutes, which was the standard incubation time for the later experiments.  
Autoradiography	  Autoradiography	  
Coomassie	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The variable SET7/9-induced methylation was even weaker under the new conditions 
and the strongly decreased methylation of cluster 3 seen in Figure 17A was no longer 
observed. Overall, the variability of the methylation intensity was rather low (equal 
methylation), which could also be caused by uneven amounts of proteins used in the 
experiments. Interestingly, the methylation was significantly stronger at pH 9 as compared to 
pH 7.2. While it took 3 days for a strong signal of the proteins methylated at pH 7.2, for pH 9 
a comparable signal was obtained already after overnight exposure, which implied a higher 
efficiency of SET7/9-induced methylation at pH 9. 
At pH 7.2, Cl1 was stronger methylated than Cl2 and wt, which were both 
comparably methylated (Fig. 18), while at pH 9 Cl2 was stronger methylated than Cl1 and wt 
(Fig. 19). The variation of the pH seemed to affect the specificity and efficiency of SET7/9 
for these two clusters. Overall, the changing the pH did not improve the specificity of SET7/9 
for the purified cluster mutants and did not allow the identification of a lysine acceptor site. 
 
7.2.4 Increasing the NaCl Concentration up to 120 mM does not affect the Methylation 
of H1.2 by SET7/9 
Since changing the pH and using an incubation time of 15 minutes was not enough to 
significantly increase the specificity of SET7/9-induced methylation of H1.2, different NaCl 
concentrations (50 mM and 120 mM, respectively) were next tested with a selected number 
of cluster mutants. Increasing the NaCl concentration was expected to affect the affinity of 
SET7/9 to the target proteins and to favor the transfer of methyl groups only to high affinity 
sites. The methylation assay was performed with the two mentioned NaCl concentrations and 
at pH 8 (Fig. 20), 7.2 or 9 (Fig 21) as previously described.  
 
Posttranslational Modification of Histone 1.4 by SET7/9 and ARTD1 Results 
 
  60 
 
 
Figure 20: SET7/9-induced methylation of H1.2 cluster mutants at pH 8 with 50 mM NaCl or 120 mM NaCl. 
Autoradiography of a 15% SDS-PAGE after methylation and separation of the different proteins (2 days 
exposure; upper panel). The lower panel shows the Coomassie stained gel to visualize the protein levels of 
SET7/9, the cluster mutants of H1.2 (Cl1, Cl1+3, Cl1+3+4, Cl1+3+5) and the C-terminal tail of H1.2 (wt). 
 
 
 
Figure 21: SET7/9-induced methylation of H1.2 cluster mutants at pH 7.2 or pH 9 with 50 mM NaCl or 120 
mM NaCl. Autoradiography of a 15% SDS-PAGE after methylation and separation of the different proteins (1 
day exposure; upper panel). The lower panel shows the Coomassie stained gel to visualize the protein levels of 
SET7/9, the cluster mutants of H1.2 (Cl1, Cl1+3, Cl1+3+4, Cl1+3+5) and the C-terminal tail of H1.2 (wt). 
 
Overall, increasing the NaCl concentration reduced the intensity of the methylation 
(Fig. 20). Again, increasing the pH to 9 resulted in stronger methylation of the proteins, even 
in the presence of higher NaCl (Fig. 21). Irrespective of the pH and NaCl concentration, H1.2 
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wt was methylated to the same extent, indicating that increasing the pH or NaCl 
concentration does not affect the specificity of SET7/9. The reduced methylation of Cl1 and 
Cl1+3+5 was again observed under the tested conditions (Fig. 20 and 21). Methylation of the 
Cl1 mutant showed a noteworthy decrease in methylation compared to the tested wt, while 
only Cl1+3+5 reduced the methylation of the C-terminus further, suggesting that the SET7/9 
methylation sites are located in different clusters. However, none of the tested conditions 
affected specificity of SET7/9 to such a degree that a single cluster could be identified as the 
main acceptor site. 
Together, the cluster mutation approach using the entire C-terminal domain failed to 
identify the SET7/9-induced methylation of H1.2. This was mainly due to the fact that most 
probably several acceptors do exist and that these sites are distributed throughout the C-
terminal end of H1.2  
 
7.2.5 The GFP-tagged full length H1.4, C-terminus, and N-terminus of H1.4 translocate 
to the Nucleus 
To gain more insight into the cellular localization of H1.4 and to establish a readout 
for the investigation of the methylation sites of H1.4 in cells, the H1.4 N-terminal domain (1-
36), the C-terminal domain (114-219) or the full-length protein (1-219) was cloned as a GFP-
fusion protein into the pEGFP-C1 vector (Fig. 22).  
 
 
Figure 22: Amino acid sequence of the GFP-fusion H1.4 constructs (Fl, C-tail, N-tail) and the newly identified 
methylation acceptor sites marked in red. 
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The different constructs were transfected into U2OS cells (as described in Material and 
Methods). The cells were analyzed by fluorescence microscopy three days after transfection 
(Fig. 23).  
 
 
Figure 23: U2OS cells 3 days after transfection of the GFP-constructs. Fluorescence microscope and phase 
contrast analysis of the three eGFP-tagged H1.4 constructs transfected into U2OS cells. 
 
The analysis revealed that all three protein constructs are expressed. Although none of 
the constructs contained a nuclear localization signal (NLS), all three proteins were observed 
in the nucleus, indicating that an amino acid sequence of the C-terminus as well as the N-
terminus might serve as a NLS. Alternatively, the fusion proteins may have translocated to 
the nucleus by a co-carrier transport with a so far unknown protein. 
Due to time constraints, the methylation-deficient mutants of H1.4 could not be tested 
in the established readout. It would, however, be interesting to study the localization of wild 
type or the methylation-deficient histone H1.4 mutants under different conditions, including 
LPS stimulation or H2O2 treatment. 
 
7.2.6 ARTD1 modifies mainly the C-terminal Domain of H1.4 
To elucidate a possible modification of H1.4 by ARTD1 in vitro, the same constructs 
as in 6.2.1 where used in a PAR-assay. PARylation of the purified, His-tagged H1.4 proteins 
was determined by incubating with recombinant ARTD1 in the presence of 32P-NAD+ and 
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activating EcoRI-linker DNA in PAR-Buffer. The reaction was stopped and the proteins were 
separated and analyzed by SDS-PAGE. After Coomassie staining, the gel was vacuum dried 
and exposed to an x-ray film. The incorporated radioactivity correlated with the methylation 
of the His-tagged protein (Fig. 24).  
 
 
Figure 24: ARTD1-induced ADP-ribosylation of full-length and different H1.4 deletion mutants. 
Autoradiography of a 15% SDS-PAGE after ADP-ribosylation and separation of the different proteins (1 day 
exposure; upper panel). The lower panel shows the Coomassie stained gel to visualize the protein levels of 
ARTD1, full-length H1.4 (FL) and different H1.4 deletion mutants (1, 2 or 3). 
 
While ARTD1 was able to PARylate full-length H1.4 and the C-terminal deletion 
mutants 1 and 2 in the presence of NAD+ and DNA, the modification of the deletion mutant 3 
expressing only the core domain and the N-terminal domain was weak. This result implied 
that ARTD1 modifies H1.4 mainly in the C-terminal domain. The intensity of the detected 
radioactivity correlated with the length of the H1.4 histone tail, suggesting multiple acceptor 
sites in the C-terminal domain of H1.4. 
 
7.2.7 Acceptor Sites for PARylation by ARTD1 on the C-terminal Tail of H1.4 
To further investigate the PARylated acceptor sites of H1.4, the C-terminal fragments 
described in 6.1 were used (fragment 1 (Fr1): expressing amino acids 114-144, fragment 2 
(Fr2): expressing amino acids 145-189, and fragment 3 (Fr3): expressing amino acids 190-
210) (Fig. 26).  
Posttranslational Modification of Histone 1.4 by SET7/9 and ARTD1 Results 
 
  64 
 
 
 
Figure 26: Scheme of the H1.4 C-terminal domain showing the cloned fragments  
 
These fragments and a full-length (FL) C-terminal domain (expressing amino acids 
114-210) were cloned into a pGEX-6P1 vector as GST fusions (linked by GGS amino acid 
repeats to minimize the steric influence of the GST-tag on the interaction of SET7/9 with the 
polypeptide). The constructs were transformed and the proteins were expressed and 
subsequently purified from E.coli according to the description in the Materials and Methods. 
While all three deletion mutants (Fr1, 2 and 3) could be purified, the full-length C-
terminal domain could not be eluted from the beads and thus the assay was performed with 
the protein still bound to the beads. The GST-tagged proteins were incubated with 
recombinant ARTD1 in the presence of 32P-NAD+ and activating EcoRI-linker DNA. The 
reaction was stopped and proteins were separated by SDS-PAGE. After Coomassie staining, 
the gel was vacuum dried and exposed to an x-ray film as described before (Fig. 27).  
 
Figure 27: ARTD1-induced ADP-ribosylation of full length and different fragments of the H1.4 C-terminal 
domain. The upper panel shows the x-ray film (1 day exposure) to identify radiolabeled proteins and the lower 
panel shows the Coomassie stained gel to visualize the protein levels of ARTD1, the full length (FL) and 
different fragments (Fr1, Fr2, Fr3) of the H1.4 C-terminal domain. 
 
 
All three deletion mutants were strongly PARylated, although Fr1 and Fr3 stronger 
than Fr2, indicating that this fragment either has a different affinity for ARTD1 or contains a 
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lower number of acceptor sites. Even though the full-length C-terminus was still bound to the 
beads, it was strongly PARylated by ARTD1. In contrast, SET7/9 was not able to methylate 
the bound C-terminal domain, which could be due to steric hindrance or the inaccessibility of 
the polypeptides for SET7/9. 
 According to this experiment the C-terminal domain of H1.4 has multiple acceptor 
sites for ARTD1 induced ADP-ribosylation.  
 
7.2.8 ARTD1- and ARTD10-dependent PARylation of H1.4 Fragments 2 and 3  
The lysines of fragment 2 and fragment 3 have already been further mutagenized for 
the determination of the methylation sites of SET7/9 in H1.4 and are thought to be one of the 
main acceptors for ARTD-induced PARylation. In order to identify PARylation sites, these 
deletion mutants were modified. Fr2 was split into four clusters (Cl1-4) and Fr3 into three 
clusters (Cl5-7). These clusters comprised all lysines and therefore many possible 
PARylation acceptor site in this region of H1.4. By overlapping PCR, all lysines in each 
cluster were mutated to arginines (Fig. 28). The new constructs were then cloned into pGEX-
6PI vector, expressed and purified. 
 
 
Figure 28: Amino acid sequence of the C-terminal tail of histone H1.4. The C-terminal domain is divided into 
the three fragments (Fr1 framed blue, Fr2 framed red, Fr3 framed green), Fr2 is split into Cl1-4 (highlighted in 
blue) (Cl1 and Cl2 share the turquois highlighted lysine), and Fr3 into Cl5-7 (highlighted in blue). The lysines, 
which were mutated to arginines, are marked in red. 
 
The wt fragments (Fr2 and 3, as positive control) as well as the cluster mutants were 
incubated with ARTD1 or ARTD10, which is a mono-APD-ribosyltransferas and thus may 
possess a different spezification, in the presence of 32P-NAD+ and activating EcoRI-linker 
DNA for 10 minutes and protein PARylation was analyzed by separating the proteins by 
SDS-PAGE (Fig. 29A and B).  
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A 
 
B 
 
Figure 29: ARTD1 and 10 induced ADP-ribosylation of wt and cluster mutants of fragments 2 and 3. A: 
Autoradiography of a 15% SDS-PAGE after ADP-ribosylation by ARTD1 and separation of the different 
proteins (10 hours exposure; upper panel). The lower panel shows the Coomassie stained gel to visualize the 
protein levels of SET7/9, the wild-type fragments (Fr2, Fr3) and the cluster mutants (Cl1-7). B: 
Autoradiography of a 15% SDS-PAGE after ADP-ribosylation by ARTD10 and separation of the different 
proteins (2 days exposure; upper panel). The lower panel shows the Coomassie stained gel to visualize the 
protein levels of SET7/9, the wild-type fragments (Fr2, Fr3) and the cluster mutants (Cl1-7). 
 
Interestingly, all cluster mutants were ADP-ribosylated to the same extent by ARTD1 
and ARTD10 as the wt counterpart (Fr2 and Fr3), suggesting that in these fragments lysine 
residues do not serve as acceptor sites. Unfortunately, the arginine residues, which replaced 
the lysines, could also serve as targets for ARTD1- or ARTD10-induced PARylation.  
A consolidated view of the results indicates that there are multiple acceptor sites for 
ADP-ribosylation in the C-terminal domain of H1.4 and that it is not possible to further 
determine these sites with our cluster mutation approach and our experimental setup. 
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7.2.9 Cluster 2 of Fragment 2 and Cluster 7 of Fragment 3 are less modified by ARTD1 
in the Presence of high NAD+ Concentrations 
To confirm these result, the same ADP-ribosylation reactions as shown in 6.2.8 were 
performed in the presence or absence of 10 nM cold (non-radioactive) NAD+ to analyze 
PARylation by western blot analysis using an antibody able to detect PAR residues (anti-
PAR, BD). The reaction was stopped and proteins were separated by SDS-PAGE. After 
transferring the proteins onto a nitrocellulose membrane, the membrane was incubate with 
the anti-PAR antibody, a secondary anti-rabbit antibody and then analyzed with the Odyssey 
Imager (Fig. 30 A and B) 
 
A 
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Figure 30: ARTD1-induced ADP-ribosylation of wt and cluster mutants of fragments 2 and 3. Western blot 
analysis of 15% SDS-PAGE using an anti-PAR antibody (upper part of panel). 1 µg GST-linker protein was 
included as control (GST). The reaction was performed in the presence or absence of NAD+. The lower panel 
shows the Coomassie stained membrane. A: GST-linker, Fr2 wt and Cl1-Cl4. B: GST-linker, Fr3 wt and Cl5-
CL7. 
 
The western blot analysis revealed that the presence of high NAD+ caused a strong 
shift of ARTD1 due to its auto-PARylation. Remarkably, this shift was similarly observed in 
both wt fragments (Fr2 and Fr3) and in Cl3-6, but not or to a lesser extent in Cl1, Cl2 and Cl7. 
These clusters thus likely contain lysine residues, which are targeted by ARTD1-induced 
ADP-ribosylation. Hence, these lysines could be the main acceptor for PARylation in the C-
terminal domain of H1.4, which supports the idea of multiple target sites. Nevertheless, 
further studies would be needed to confirm these findings.  
 
7.2.10 PARylation by ARTD1 inhibits Methylation by SET7/9 
To study the crosstalk of posttranscriptional ADP-ribosylation and methylation, a 
sequential ADP-ribosylation and methylation assay was performed. 
H1.4 fl and the wt of fragment 3 (Fr3) were both incubated with either wt ARTD1 or 
with an enzymatically inactive ARTD1 mutant in the presence of cold NAD+ and activating 
EcoRI-linker DNA (15 minutes, 30°C). PJ-34 was added either before or after ADP-
ribosylation to inhibit PARylation (5 minutes incubation time). Next, SET7/9 and 14C-SAM 
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were added and the reaction was incubated for 1 hour at 30°C. Protein methylation was 
analyzed by separating the proteins by SDS-PAGE (Fig. 25).  
 
 
Figure 25: SET7/9 induced methylation of H1.4 fl and wt fragment 3 in the presence or absence of ADP-
ribosylation. Autoradiography of a 15% SDS-PAGE after methylation and separation of the different proteins (2 
days exposure; upper panel). The lower panel shows the Coomassie stained gel to visualize the protein levels of 
SET7/9, ARTD1, full length H1.4 and the wild-type fragment (Fr3). 
 
As shown in the autoradiography, Set7/9-dependent methylation is prevented by 
ARTD1-dependent ADP-ribosylation of H1.4. This result could imply a structural proximity 
of the methylated lysine residues and the ADP-ribosylation acceptor site, which leads to 
steric hindrance. This crosstalk of ADP-ribosylation and methylation in H1.4 strengthens the 
importance of histone modifications and is an additional interaction in the “histone code”. 
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8 Discussion 
8.1 Linker Histone H1 Methylation by SET7/9 
SET7/9 was identified as a mono-methyltransferase for H3K4 73,167. In the course of 
our studies, SET7/9 was found to methylate the C-terminal fragment of linker histone H1.4, 
while neither the globular nor the N-terminal part were modified. Methylation was abolished 
by the addition of DNA to the methylation reaction. In order to identify the methyl acceptor 
sites in the lysine rich C-terminus, a cluster mutation approach was pursued. Since different 
cluster mutants of the entire histone H1.2 C-terminus were already available 177 and the 
sequence of the H1 variants is rather conserved, these constructs were chosen for the initial 
analysis. The variability of the methylation intensity of the cluster mutants was weak and 
adjustments in pH and the NaCl concentration did not increase the specificity of SET7/9 for 
H1.2. At pH 9, the methylation efficiency was strongly increased. However, the cluster 
mutation approach was not successful for H1.2, since methylation by SET7/9 could not be 
ascribed to only one cluster, indicating that SET7/9 methylates several lysine residues, which 
are distributed throughout the entire C-terminal domain of H1.2. To increase the chance to 
identify the methylation sites, the C-terminus of H1.4 was divided into three C-terminal 
fragments. SET7/9 mainly methylated H1.4 in fragment 2 (amino acids 145-189) and 3 
(amino acids 190-219), whereas fragment 1 (amino acids 114-144) was only weakly 
methylated. A cluster mutation approach then identified six KAK sites, which were 
methylated in vitro at the last lysine residue by recombinant SET7/9. The second cluster 
approach was likely successful because the analyzed H1.4 fragments were smaller (in 
average 35 amino acids) as compared to the fragments investigated for H1.2 (full length C-
terminus, 98 amino acids). 
It is striking that SET7/9-induced methylation was strongly enhanced at a higher pH 
(9 versus 7.2). This might be due to the different pKa’s of lysine (2.18, 8.95 and 10.53), 
which would lead to the deprotonation of lysines at higher pH, indicating that a fully 
protonated lysine is not a good methyl group acceptor. 
The C-terminal domain of H1.4 acquires a specific secondary structure when bound 
to DNA 40, stabilizes the folding of the nucleosome array into chromatin fibers, and is needed 
for the high affinity binding to chromatin 41. Addition of DNA to the methylation reaction 
abrogated the methylation of SET7/9 completely. It is thus tempting to speculate that 
SET7/9-induced methylation of the C-terminal domain affects the binding to DNA or even 
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the stabilization of the nucleosome arrays, leading to less compact chromatin and increasing 
the accessibility for other proteins to the DNA. 
The binding affinity of the different H1 subtypes correlates with the length of the C-
terminal domain, with H1.4 and H1.5 having the highest affinity 45. Modifications such as 
SET7/9-induced methylation of the C-terminal domain might thus modulate the kinetics of 
H1 chromatin exchange by altering the interaction of H1 with other structural protein 
components of chromatin. For example, it was shown that ongoing phosphorylation is needed 
for histone H1 mobility 48.  
 
 
Figure 31: Amino acid sequence of the human linker histone H1.4 with the so far known post-translational 
modification sites. PARylation (PAR) is marked in green and phosphorylation (P) in blue. Methylation (me) 
sites with the number indicating the methylation state, as well as the six newly identified KAK motifs, are 
indicated in red. 
 
The biological relevance and in vivo function of methylation by SET7/9 is still 
unclear. However, stimulation and repression of other post-translational modifications might 
be one possible function. In comparison to core histones, very little is known about the 
modifications and consequent modifiers of the linker histones. For example, the four last 
lysine residues, which showed the strongest modification by SET7/9, are located very close 
to already known CDK phosphorylation sites. In addition, interactions between K26 
dimethylation and AuroraB-mediated phosphorylation of S27 have been shown earlier 173. A 
comparable interaction could exist between phosphorylation by CDKs and SET7/9-induced 
methylation of H1.4. For example, S172 and S187 are not only phosphorylated during 
mitosis and their modification in interphase is associated with transcription and chromatin 
relaxation 176. The close proximity of these post-translational modifications could implie a 
possible crosstalk.  
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The first H1.4 methylation site to be discovered was K26, which is catalyzed by 
Enhancer of zeste homolog 2 (Ezh2). Heterochromatin protein 1 (HP1) binding to this 
methyl-group induces transcriptional repression, whereas phosphorylation of H1.4 on S27 
abolishes HP1 binding 60. H1.4K26 methylation increases the residence time of H1.4 at the 
chromatin 178. Furthermore, due to technical improvements in mass spectrometry, new H1 
modification sites of different PTMs have lately been identified, but the function of the 
majority of these modifications is still unknown. One of them is H1.2K187, which is 
methylated by the histone lysine methyltransferases G9a and Glp1 177, but its function is still 
unknown.  
In vitro experiments identified H3K4 as a hindrance for repressive histone modifiers, 
so that H3K4 modification by SET7/9 was associated with transcriptional activation 75. 
However, the global H3K4 methylation levels are not changed in SET7/9 knockout mice 179. 
A prerequisite to test a similar gene-specific function for H1 methylation by SET7/9 is the 
availability of an antibody exclusive for this modification. Such an H3K4-specific antibody 
would allow an in-depth analysis of the impact of SET7/9-dependent methylation on 
individual genes and promoters. Since variant H1.4 has one of the strongest affinities for 
chromatin 45 and the C-terminal domain was described to interact with HP1, one might be 
tempted to propose that the methylation of H1.4 by SET7/9 leads to an even stronger binding 
of H1.4 to chromatin 41. Therefore, SET7/9 methylation could potentially be a major player 
in the repression of transcription, but this has to be a topic of further studies. 
The nuclear distribution and mobility of wt GFP-H1.4 and the K6R mutant was 
compared by live-cell imaging and FRAP experiments, respectively, by Ingrid Kassner. We 
neither observed a difference in the localization nor in the mobility under the tested 
conditions. It is possible that variations in mobility can only be seen in cells overexpressing 
or lacking SET7/9, as it is the case for ARTD1 methylation 180. The H1.4 fusion proteins with 
photoactivatable GFP, which have been used to determine the nuclear localization of full 
length, C-terminal and N-terminal tails of H1.4 in U2OS cells on both eu- and 
heterochromatin, may be used in future studies. It would be interesting to monitor the 
dynamics of H1.4 as a function of SET7/9-induced methylation in specific nuclear regions 
and under defined conditions. 
Genome-wide binding studies identified H1 to reside mainly on inactive genes, 
whereas ARTD1 showed reciprocal binding to chromatin 128. Hence, it is interesting to 
speculate that the exchange of H1 and ARTD1 on their target promoters during gene 
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activation is regulated by SET7/9 induced methylation. Other chromatin binding factors, 
which assist in accumulation and displacement of H1 and ARTD1 from chromatin, could be 
regulated by methylation and thus induce adjustments in chromatin structures.  
 
8.2 Linker Histone H1 Modification by ARTD1 
ADP-ribosylation by ARTD1 affects inter- and intracellular signaling, cell cycle 
regulation, chromatin remodeling, DNA replication, transcription, DNA repair, somatic 
recombination, regulation of telomere length, inflammation and cell death via apoptosis or 
necrosis, and thus plays a critical role in many cellular processes 105,120. 
 In this study we identified the acceptor site for ARTD1-induced modification in linker 
histone H1. It was shown, that ADP-ribosylation is mainly found in the C-terminal domain of 
H1.4 and that there have to be multiple acceptor sites for this modification. An exact 
identification of the amino acid residues was not possible. There was also no significant 
difference in ARTD1- and ARTD10-induced modification in H1.4. It may have been 
impossible to identify the acceptor sited due to the cluster mutation approach itself, which 
may not be suited for the amount of target sites. In addition, the arginines, which replaced the 
lysines, could potentially also serve as acceptors for ADP-ribose.  
However, in a PAR-assay with increased NAD+ concentrations, a reduced shift of 
mutated H1.4 (Cl1, Cl2 and Cl7) was observed. This could indicate, that the arginines, which 
were thought to be acceptor sites, are not ADP-ribosylated in H1.4 and lysines are the main 
target of ARTD1-induced modification. Due to time restrictions, this has to be the focus of 
further studies. 
 
8.3 Crosstalk of ARTD1 and SET7/9 on H1.4  
Epigenetics is known as heritable changes in gene expression or cellular phenotypes 
that occur without changes in the underlying DNA sequence. DNA methylation, histone 
modification and chromatin alterations thus comprise epigenetic modifications. The results 
described in this study further strengthen the importance of ARTD1 and histone ADP-
ribosylation as components of the histone code 171. ARTD1-induced PARylation of linker 
histone H1 impacts subsequent methylation by SET7/9. ADP-ribosylation is a bulky 
modification with strong, negative charges, which most likely inhibits H1 modification by 
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SET7/9. This is comparable to phosphorylation, which reduces methylation of close SET7/9 
target lysine residues 76. 
The facts that ARTD1 is able to ADP-ribosylate all core histones and the linker 
histones 112 and that the size and branching of the polymers can vary under different 
conditions, increase the complexity of ARTD1-induced histone modification even more. 
Hence, it is important for future studies to not only concentrate on the impact of ADP-
ribosylation on other histone modifications, but moreover on the regulation of ARTD1-
dependent histone modification itself.  
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